Body · Sources

Sleep apnea

Also called OSA · obstructive sleep apnea · CPAP · snoring pauses · AHI · home sleep test · sleep study · apnea hypopnea

Named sources. May contain inaccuracies or be incomplete. Not medical, legal, financial, or other professional advice.

Obstructive sleep apnea means breathing repeatedly narrows or stops because the upper airway closes during sleep. A full night in bed can therefore leave someone sleepy or unrefreshed. Witnessed pauses, gasping and disruptive daytime sleepiness are reasons to seek clinical evaluation. Avoid driving when sleepy and arrange another way to travel. A sleep study identifies the pattern; treatment then aims to improve breathing and daily function. Follow-up checks its effects and whether it can be used consistently.

What happens during sleep apnea?

The useful starting point is the breathing pattern, rather than how loud someone snores or which device they own.

Understand the interruption behind an unrefreshing night

The upper airway is the passage through the nose, mouth and throat that carries air toward the lungs. In obstructive sleep apnea, or OSA, that passage repeatedly narrows or closes while the person is asleep. Breathing effort can continue even when little air moves. An apnea is a pause in airflow; a hypopnea is a qualifying reduction in airflow. Events can lower blood oxygen or briefly rouse the brain, interrupting sleep without a remembered awakening. NHLBI explains why time in bed and restorative sleep can diverge: the person may have had enough opportunity to sleep, while breathing repeatedly disrupted it. OSA is the most common type. Central sleep apnea involves a different problem with the signals that drive breathing, so an OSA treatment explanation does not cover every form of apnea.

Sleep Apnea — What Is Sleep Apnea?Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea

Recognize why apnea belongs in everyday health discussions

Terry Young and colleagues' 1993 Wisconsin Sleep Cohort paper used overnight laboratory studies in 602 employed adults aged 30–60, rather than only people already referred to a sleep clinic. It found previously unrecognized sleep-disordered breathing in both women and men. Paul Peppard's 2013 analysis later used 1,520 cohort participants aged 30–70 and modeled prevalence with age, sex and body mass index. Its estimates rose when applied to later US weight distributions. These studies helped establish that the problem belongs in ordinary adult health conversations. They were population studies, not trials showing which treatment any one person needs. Their historical percentages also depend on the scoring rules and samples used; neither an old prevalence estimate nor a risk factor can tell you what happened in your own airway last night.

The occurrence of sleep-disordered breathing among middle-aged adults Increased prevalence of sleep-disordered breathing in adults

Make room for symptoms beyond stereotypical snoring

A sleepy, heavier, older man who snores is one recognizable presentation, but it is not the definition of OSA. NHLBI describes women reporting fatigue, headaches or insomnia, and notes that risk increases during and after menopause. Sonia Ancoli-Israel's sleep-and-aging research also makes older-adult sleep symptoms a legitimate subject of assessment. Feeling tired is broader than sleepiness: fatigue can mean low energy, whereas sleepiness means difficulty remaining awake. Neither is specific to apnea. Someone living alone may have no witness to a pause, and someone who snores may have another explanation. The practical response is to describe the actual symptoms and history, including medicines and nighttime urination, rather than deciding whether you look like the usual patient.

Sleep Apnea — Symptoms Sleep Apnea — Sleep Apnea and Women Sonia Ancoli-Israel — UCSD Profiles Sleep Apnea — Diagnosis

What belongs in the first conversation?

Bring the pauses someone has noticed

If someone describes snoring followed by silence, a gasp or a choking sound, report the sequence to a clinician. NHLBI lists stopped-and-restarted breathing and gasping as symptoms worth discussing. Snoring is vibration in a narrowed passage; a witnessed pause raises a different question about interrupted airflow. A partner's description or an existing recording can help explain that question, but neither establishes the event count or the cause. You do not need someone to monitor every night before making an appointment. Bring what is already known, along with daytime sleepiness, the usual sleep schedule and any relevant health conditions. A clinician can then decide whether a sleep study is appropriate.

For an invented example, a household member notices a pause followed by gasping and the sleeper reports struggling to stay alert during the day. Their useful account keeps the two observations separate: what was witnessed at night and what the person experiences afterward. It does not turn a remembered pause into an hourly event count. They bring the existing information to a clinician rather than delaying until someone has recorded a whole night.

If a later night sounds quieter, that single change does not establish whether the underlying question is resolved. The next step still depends on clinical assessment and any indicated testing. Sleepiness affecting driving requires immediate attention to safe transport. The example shows what an observation can contribute—and why it cannot supply the diagnosis, severity or treatment setting by itself.

Sleep Apnea — Symptoms Sleep Apnea — Diagnosis Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea

Explain how the next day feels after enough time in bed

If a full-looking night still leaves you unrefreshed, describe what that means: struggling to stay awake, needing unexpected naps, waking with a headache or having difficulty concentrating. NHLBI includes these kinds of sleep and daytime symptoms in its public education. The connection is plausible because OSA can interrupt sleep repeatedly, but a symptom is not proof of that mechanism. Short sleep, insomnia, body-clock timing, medicines and other health problems can also contribute. A sleep history helps distinguish lack of sleep opportunity from poor sleep despite enough opportunity. If you have nodded off while driving or at work, lead with that safety information rather than leaving it until the end of the visit.

Sleep Apnea — Symptoms Sleep Apnea — What Is Sleep Apnea?Sleep Apnea — Diagnosis Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea FAQs: Sleep Disorders, Fatigue, and Professional Operators

Ask what the proposed sleep test will measure

If you have been offered a home test, ask why it fits your history and what happens after a negative or unclear result. Vishesh Kapur's AASM task force recommends technically adequate home testing for selected uncomplicated adults whose symptoms suggest increased risk of moderate-to-severe OSA. Uncomplicated means that the history does not raise important competing breathing or sleep problems requiring broader monitoring. A laboratory study records more of the sleep itself as well as breathing. The distinction is useful when you have insomnia, heart or lung disease, opioid use or another relevant condition. A convenient location is one consideration; the more important question is whether the test can answer the clinical question.

Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea Sleep Apnea — Diagnosis

Describe the treatment difficulty that needs solving

If you already have a diagnosis, say both what improved and what prevents treatment use. Air leaking toward the eyes, dry mouth, nasal congestion, pressure discomfort or trouble falling asleep are useful specifics. Patil's AASM PAP guideline includes troubleshooting and objective monitoring as part of treatment, rather than treating a prescription as the endpoint. Ramar's oral-appliance guideline likewise includes dental oversight and follow-up sleep testing. A treatment can lower breathing events under ideal conditions yet provide little benefit if it cannot be used during sleep. Bringing the actual obstacle lets the care team consider fit, support or an alternative. It does not require you to choose a pressure, appliance or operation yourself.

Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline Clinical Practice Guideline for the Treatment of Obstructive Sleep Apnea and Snoring with Oral Appliance Therapy: An Update for 2015 Sleep Apnea — Living With

How do the test and its numbers fit together?

Let clinical testing turn a suspicion into a diagnosis

Polysomnography, often shortened to PSG, is the laboratory sleep study. It records signals that identify sleep and wakefulness alongside breathing, oxygen and other measurements. A home sleep apnea test, or HSAT, generally collects fewer signals. Kapur's 2017 AASM guideline places both inside a comprehensive evaluation and follow-up pathway. It recommends laboratory testing when significant cardiorespiratory disease, potential breathing-muscle weakness, suspected inadequate ventilation, chronic opioid use, previous stroke or severe insomnia makes a limited home study unsuitable. Hypoventilation means not moving enough air to meet the body's needs; it is a broader question than counting upper-airway obstructions. Questionnaires can help identify risk, but a questionnaire score alone cannot diagnose OSA. Test selection is therefore about what could be missed, as well as what might be found.

Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea Sleep Apnea — What Is Sleep Apnea?

Read events per hour with the correct denominator

The apnea-hypopnea index, or AHI, counts qualifying breathing events per hour actually asleep. Many home tests instead report a respiratory event index, or REI, using monitoring time because they do not directly identify all sleep and wake periods. For example, 60 events divided by six hours asleep gives 10 per hour; dividing the same events by eight monitored hours gives 7.5. This arithmetic illustrates why awake time can dilute a home-test result; it is not a way to rescore your own study. AASM's public explanation also notes that many home tests miss events associated only with brief brain arousals. Adult severity categories commonly start at 5, 15 and 30 events per hour. A clinician reads those bands together with symptoms, oxygen changes and test quality, rather than treating the number as a complete account of burden.

FAQs: Sleep Disorders, Fatigue, and Professional Operators Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea Obstructive Sleep Apnea in Adults: Screening Clinical Guideline for the Evaluation, Management and Long-term Care of Obstructive Sleep Apnea in Adults

Which hours are in the denominator?

Keep the guide’s 60 qualifying events fixed to isolate the arithmetic. In this invented example, all occur during six hours asleep. There are no unusable signal periods. The bars share a nine-hour scale; they group totals, not the order of a real night.

Full recording · 9 hours: Six hours asleep (blue), two awake hours the home test does not identify (striped), and one awake hour it does identify (outlined).
Monitoring time · 8 hours: Remove the one identified awake hour: 9 − 1 = 8. The two unidentified awake hours remain in this example’s monitoring time.
Measured sleep time · 6 hours: A sleep study that identifies sleep uses the six hours actually asleep for this AHI calculation.

AHI: 60 ÷ 6 = 10 events/hour.
REI: 60 ÷ 8 = 7.5 events/hour.
The lower number here comes from a larger denominator, not fewer events.

Monitoring time excludes identified wake and unusable signal; it is not automatically the full recording or true sleep time. Real tests can also detect or score different events. These deliberately fixed counts are not a prediction of two test results, a diagnosis or a way to rescore your report. Review the actual study with its clinician.

Basis: AASM home-testing position statement and recording-time study.

Compare scoring rules before comparing two reports

An oxygen desaturation is a fall in the blood-oxygen reading. An arousal is a brief shift toward wakefulness detected by brain-wave recording. The diagnostic guideline explains that one hypopnea rule accepts a 3% oxygen drop or an arousal, while another requires a 4% oxygen drop without counting arousal alone. The resulting AHI can differ even for the same person. Home equipment, sleep time, sensor quality and the amount of back-sleeping or dream sleep can add further differences. This explains why a report deserves interpretation rather than a simple pass/fail reading. Ask which event rule was used and whether the recorded night answered the original question. AASM recommends PSG after a negative, inconclusive or technically inadequate single HSAT; it also allows consideration of another PSG when an initial laboratory result is negative but clinical suspicion remains.

Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea Polysomnography for Obstructive Sleep Apnea Should Include Arousal-Based Scoring: An American Academy of Sleep Medicine Position Statement

What do the main treatments actually do?

Understand PAP as support for the airway during sleep

Positive airway pressure, or PAP, supplies pressurized air through a mask to help hold the airway open. CPAP supplies a continuous pressure; APAP adjusts pressure within the prescribed setup; bilevel PAP uses different pressures for breathing in and out. These are different delivery approaches, not rankings of who has the best machine. Susheel Patil and colleagues' 2019 guideline strongly recommends PAP for adults with OSA and excessive sleepiness, and conditionally recommends it for impaired sleep-related quality of life or hypertension. It supports CPAP or APAP for ongoing routine OSA care. The strength of each recommendation reflects the evidence and tradeoffs for that outcome. PAP supports breathing while used; a few comfortable nights do not establish that the underlying OSA has disappeared.

Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline Sleep Apnea — Treatment

Connect treatment benefit to breathing control and regular use

Efficacy asks whether a treatment controls breathing when applied. Effectiveness also asks whether the person can use it in ordinary life. In a three-month, multicenter study of adults with severe OSA, Terri Weaver and colleagues found that longer nightly CPAP use was associated with a greater likelihood of returning to normal sleepiness and daily-function measures. Different outcomes had different use-response patterns. The study was not a randomized assignment to a universal safe number of hours. NHLBI advises using prescribed PAP during all sleep, including naps, and bringing the device when traveling. The useful lesson is to solve a mask or comfort problem early, so more of the actual sleep period receives treatment, rather than treating an administrative minimum as proof that every outcome is protected.

Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning Sleep Apnea — Living With

Ask how a custom oral appliance will be fitted and checked

A mandibular advancement appliance holds the lower jaw farther forward to help keep the airway open. Ramar, Dort and their AASM/AADSM colleagues recommend considering oral appliances for adults with OSA who cannot tolerate CPAP or prefer an alternative. Their guideline favors a custom, adjustable device over a non-custom device. Adjustable means that a qualified dentist can change the position as part of the treatment process. This is not the same as buying an ordinary snoring guard. The dentist checks dental or jaw effects and changes in the bite; the sleep clinician checks whether breathing is controlled. Follow-up sleep testing matters because quieter snoring and a comfortable fit do not by themselves establish that OSA is adequately treated.

Clinical Practice Guideline for the Treatment of Obstructive Sleep Apnea and Snoring with Oral Appliance Therapy: An Update for 2015 Use of polysomnography and home sleep apnea tests for the longitudinal management of obstructive sleep apnea in adults: an American Academy of Sleep Medicine clinical guidance statement

Keep weight-related treatment in the full breathing plan

Weight management can help when excess body weight contributes to OSA, but the degree of improvement varies and another contributor can remain. In December 2024, the FDA approved tirzepatide, sold as Zepbound, for moderate-to-severe OSA in adults with obesity, together with a reduced-calorie diet and increased physical activity. The supporting studies included 469 adults without type 2 diabetes, followed for 52 weeks: one trial enrolled PAP users, the other people unable or unwilling to use PAP. Malhotra and colleagues reported larger reductions in AHI than with placebo. This is a studied prescription option for a defined population, not evidence that any weight-loss product cures apnea. Medication selection requires review of adverse effects and contraindications; FDA identifies gastrointestinal effects and serious risks, including restrictions for medullary thyroid cancer history or MEN2. Weight loss or less snoring alone is not permission to stop prescribed airway treatment.

FDA Approves First Medication for Obstructive Sleep Apnea Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity Use of polysomnography and home sleep apnea tests for the longitudinal management of obstructive sleep apnea in adults: an American Academy of Sleep Medicine clinical guidance statement

Read trial improvements as averages with clear limits

In SURMOUNT-OSA, the average starting AHI was approximately 50 events per hour and average body mass index was approximately 39. At 52 weeks, the additional AHI reduction with tirzepatide compared with placebo averaged 20.0 events per hour in the non-PAP trial and 23.8 in the PAP trial. These are between-group differences, not a promised decrease for each person. A lower average AHI also does not mean every participant's apnea resolved. The trials measured breathing events, weight and other outcomes over a year; they did not establish that every long-term cardiovascular complication is prevented. Gastrointestinal adverse effects were most common, and the manufacturer funded the trials. The size of the breathing improvement is useful evidence, while the population, follow-up duration and sponsor remain part of interpreting it.

Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity FDA Approves First Medication for Obstructive Sleep Apnea

Where do reasonable clinical choices differ?

Some questions involve genuinely incomplete outcome evidence. Others involve choosing between supported approaches for different people; that is not a disagreement over whether apnea exists.

Separate population screening from evaluating your symptoms

Screening means looking for a condition in people who are not presenting with a recognized concern. The 2022 USPSTF review found insufficient evidence to judge the overall benefit versus harm of routine adult OSA screening. Its I statement includes adults whose symptoms are unrecognized or not reported as a concern; it is neither a recommendation for nor against screening. It does not apply to someone presenting with symptoms or referred for suspected OSA. Professional groups also differ on targeted screening of higher-risk populations because risk, evidence thresholds and settings differ. This uncertainty is about a preventive strategy, not a reason to dismiss gasping or disabling sleepiness. Tell a clinician about the concern you actually have, rather than waiting for a universal screening policy.

Obstructive Sleep Apnea in Adults: Screening Obstructive Sleep Apnea Screening Health Advisory

Match the convenience of home care to the information needed

Home testing and home initiation of APAP can make care easier to access for suitable adults. A laboratory pathway can answer broader questions or provide supervised pressure adjustment. Patil's guideline supports either home APAP initiation or laboratory titration in adults without significant comorbidities, and either CPAP or APAP for ongoing treatment. Titration means adjusting pressure to control breathing events, not diagnosing severity from a pressure number. These supported alternatives do not make remote care automatically inferior or a shipped device automatically sufficient. Both approaches need education, monitoring and a route to solve problems. Discuss the medical history, available support and what will happen if symptoms, leak or machine data do not match the expected response.

Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea Use of polysomnography and home sleep apnea tests for the longitudinal management of obstructive sleep apnea in adults: an American Academy of Sleep Medicine clinical guidance statement

Choose outcomes that matter alongside the AHI

OSA is associated with hypertension and cardiovascular disease, and the American Heart Association discusses it as relevant to heart care. Association alone does not prove that a particular treatment prevents heart attacks or strokes. In the SAVE randomized trial, 2,717 adults with moderate-to-severe OSA and existing coronary or cerebrovascular disease received usual care with or without CPAP. Most were minimally sleepy; average CPAP use was 3.3 hours nightly. Over an average 3.7 years, adding CPAP did not significantly reduce the main combined cardiovascular endpoint, while snoring, sleepiness and quality-of-life measures improved. This does not erase symptom benefits or settle the question for every population and pattern of use. It does explain why clinicians should discuss the expected outcome specifically, while continuing ordinary blood-pressure and cardiovascular care.

CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline

Discuss selected surgery as an evaluated option

Airway surgery changes anatomy; implanted hypoglossal nerve stimulation activates a nerve controlling tongue movement to help maintain airflow. Bariatric surgery addresses obesity rather than directly reshaping the throat. None is interchangeable with the others. David Kent's 2021 AASM guideline recommends discussing sleep-surgeon referral with PAP-intolerant or PAP-unaccepting adults with BMI below 40, and bariatric referral with eligible adults with obesity and BMI at least 35 who cannot accept or tolerate PAP. It generally suggests PAP first even with a major airway anatomic abnormality. These referral recommendations are not an instruction to have an operation. Selection, risks, possible residual OSA and patient preferences still need specialist assessment. The practical choice is an informed consultation when appropriate, not treating a social-media transformation as an operative plan.

Referral of adults with obstructive sleep apnea for surgical consultation: an American Academy of Sleep Medicine clinical practice guideline Sleep Apnea — Treatment

How can care keep working over time?

Bring symptoms and device data to the same follow-up

A machine download can report use, leak and estimated residual events: breathing events detected while treatment is running. These are useful observations, but the device does not measure every aspect of sleep or directly certify next-day alertness. AASM describes device estimates as manufacturer-dependent, and its follow-up guidance allows laboratory assessment of unexplained PAP data. Report how you actually feel alongside the download. Improvement in the report and persistent sleepiness can coexist, so a clinician may need to assess sleep opportunity, other conditions or whether treatment is working as expected. A low displayed number is information for that conversation, not a reason to dismiss continuing symptoms.

FAQs: Sleep Disorders, Fatigue, and Professional Operators Use of polysomnography and home sleep apnea tests for the longitudinal management of obstructive sleep apnea in adults: an American Academy of Sleep Medicine clinical guidance statement Sleep Apnea — Diagnosis

Treat comfort problems as solvable care problems

Leak, dryness, congestion, claustrophobia and difficulty sleeping with a mask can limit usable treatment time. NHLBI advises contacting the care team about these problems; mask choices, humidification or adjustments made by the team may help. The appropriate change depends on what is causing the problem, rather than the most popular suggestion online. Explain whether discomfort happens as you fall asleep, throughout the night or when you wake. Patil's recommendations support education and early troubleshooting, including selected remote monitoring. Needing support does not show that you failed treatment. It identifies the practical problem that has to be solved for the prescribed therapy to provide benefit.

Sleep Apnea — Living With Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline

Ask whether a change makes reassessment useful

Sean Caples and colleagues' 2021 AASM guidance distinguishes follow-up from automatically repeating a sleep study. Routine retesting is not recommended for an asymptomatic person doing well on PAP. Reassessment can be appropriate when symptoms persist or recur despite good use, when weight changes substantially, when cardiovascular disease changes or when unexplained device data raise a question. The guidance recommends testing the response to non-PAP treatments, which can include an oral appliance or surgery. This gives a concrete question for a follow-up visit: what has changed, and what would another test help decide? A clinician determines the timing and method; quieter snoring or a better morning alone does not answer it.

Use of polysomnography and home sleep apnea tests for the longitudinal management of obstructive sleep apnea in adults: an American Academy of Sleep Medicine clinical guidance statement

Keep dental follow-up with an oral-appliance plan

An oral appliance is a continuing treatment, not just a fitting appointment. The lower-jaw position may be adjusted, and a dentist checks comfort, tooth and jaw effects, and changes in how the teeth meet. That meeting is the bite, or occlusion. The AASM/AADSM guideline calls for periodic dental and sleep-clinician visits and follow-up sleep testing. Report new dental discomfort or a changed bite rather than quietly accepting it as the price of quieter nights. The care team needs both parts of the picture: whether the appliance is tolerable and whether it controls the breathing disorder. A device being comfortable and a device being effective are separate questions.

Clinical Practice Guideline for the Treatment of Obstructive Sleep Apnea and Snoring with Oral Appliance Therapy: An Update for 2015

Keep everyday sleep habits beside apnea care

A regular opportunity to sleep and an agreed lifestyle plan can support care, but neither explains away measured airway obstruction. NHLBI describes physical activity, weight management and selected side-sleeping among possible parts of treatment. Side-sleeping is relevant when position influences airway blockage; it is not evidence that every case resolves in that position. Ask about alcohol, sedating medicines and other substances in the history rather than making unreviewed medication changes. Continue the agreed breathing-treatment plan while the clinician reviews its response. For everyday sleep duration and routines, see STUDself. General sleep habits and treatment of a breathing disorder answer related, but different, questions.

Sleep Apnea — Treatment Sleep Apnea — Diagnosis Use of polysomnography and home sleep apnea tests for the longitudinal management of obstructive sleep apnea in adults: an American Academy of Sleep Medicine clinical guidance statement

What should a claim check conclude?

These are evidence judgments about the claims below, not a diagnosis or clearance for an individual. The fuller explanations above show what each judgment depends on.

Bring snoring with breathing pauses to clinical care

Claim: Loud snoring with breathing pauses is a reason to seek clinical evaluation. Verdict: established. NHLBI identifies pauses, gasping and daytime sleepiness as symptoms to discuss. This supports evaluation; it does not establish OSA from sound alone or mean that every person who snores has apnea.

Sleep Apnea — Symptoms

Use a wearable alert to open the testing question

Claim: A wearable sleep score can diagnose obstructive sleep apnea. Verdict: not. A generic sleep score is not the clinician-selected diagnostic study in AASM guidance. Some consumer devices have specifically authorized notification features, which are different from a general score and still require clinical interpretation and evaluation. An alert can prompt care; a reassuring score cannot finish the diagnostic question.

Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea Sleep Apnea Notification Feature (SANF) — FDA 510(k) Summary K240929 Apple Watch has warned me about possible sleep apnea for 3 months straight. Has anyone else experienced this?

Understand why PAP is a major treatment option

Claim: PAP is first-line treatment for many adults with moderate or severe OSA. Verdict: established. PAP is a major airway-support treatment. Patil's guideline most directly states a strong recommendation for excessive sleepiness and conditional recommendations for sleep-related quality of life and hypertension. Severity is interpreted with that clinical picture, rather than used here as a self-prescription rule.

Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline Sleep Apnea — Treatment

Confirm the breathing response after weight change

Claim: Losing weight always replaces the need to treat moderate-to-severe OSA. Verdict: not. Weight-related interventions can improve OSA in appropriate populations; improvement is not universal resolution. AASM follow-up guidance allows reassessment after substantial weight change. The result and clinical review, rather than the scale alone, inform whether an existing treatment should change.

Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity Use of polysomnography and home sleep apnea tests for the longitudinal management of obstructive sleep apnea in adults: an American Academy of Sleep Medicine clinical guidance statement

Read universal screening claims as unsettled evidence

Claim: Every adult should be screened for OSA even with no symptoms. Verdict: disputed. USPSTF found insufficient evidence to judge routine screening, while some professional advice supports screening selected high-risk groups. Insufficient evidence is not proof that screening cannot help. It does not prevent assessment when someone presents with symptoms or concern.

Obstructive Sleep Apnea in Adults: Screening Obstructive Sleep Apnea Screening Health Advisory

Ask about a custom oral appliance when it fits the care plan

Claim: Custom oral appliances can be an option when PAP cannot be used. Verdict: established. The AASM/AADSM guideline supports consideration for CPAP intolerance or a preference for alternate therapy, with qualified dental care and follow-up testing. That conclusion applies to a supervised treatment pathway, not every retail mouthguard.

Clinical Practice Guideline for the Treatment of Obstructive Sleep Apnea and Snoring with Oral Appliance Therapy: An Update for 2015

Review treatment changes with the prescribing clinician

Claim: A few good nights mean you can stop prescribed PAP on your own. Verdict: talk. Better nights may reflect effective treatment rather than disappearance of the disorder. PAP benefits depend on use, and changes after improvement, weight loss or another intervention belong in a clinical reassessment. This is not a rule to continue through every adverse effect without help: contact the treating team when treatment is causing problems.

Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning Use of polysomnography and home sleep apnea tests for the longitudinal management of obstructive sleep apnea in adults: an American Academy of Sleep Medicine clinical guidance statement Sleep Apnea — Living With

What is one useful move now?

Describe nighttime breathing and daytime symptoms to a clinician

Arrange a clinical conversation about concerning breathing or daytime symptoms. Prepare four short lines: what someone has heard overnight, whether you gasp or wake choking, what staying awake feels like the next day, and whether driving or work has become unsafe. NHLBI describes the history, risk factors and medicines as part of evaluation. A diary can help organize information, but you do not need a perfect two-week record before care. These observations help the clinician decide what needs investigation. They do not provide a home diagnosis or establish a need for a device.

Sleep Apnea — Diagnosis Sleep Apnea — Symptoms FAQs: Sleep Disorders, Fatigue, and Professional Operators

Try recording the pattern already available

Write down the usual sleep hours, snoring or observed pauses, gasping, morning headaches, naps and any unintended daytime sleep. Include existing observations from someone sharing the room and the medicines or substances that could affect sleep. A sleep diary can make this easier to describe, as NHLBI explains. It does not measure AHI or prove which condition is responsible. If sleepiness threatens safety, seek help promptly instead of waiting to complete a log.

Sleep Apnea — Diagnosis Sleep Apnea — Symptoms FAQs: Sleep Disorders, Fatigue, and Professional Operators

Try asking about the whole testing and treatment pathway

At the visit, ask: Why this test, what happens if it is unclear, and how will treatment response be checked if OSA is found? If treatment is already difficult, bring the specific obstacle and ask what support or alternatives fit the result. Kapur, Patil and Ramar's guidelines describe different parts of that connected pathway. The purpose is to understand the next decision and the follow-up, rather than to leave with an unexplained number or a device you cannot use.

Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline Clinical Practice Guideline for the Treatment of Obstructive Sleep Apnea and Snoring with Oral Appliance Therapy: An Update for 2015

When should safety come first?

Arrange a safe alternative when you are too sleepy to drive

If you have nodded off at a light, fallen asleep driving or had a near miss, do not make the next trip a test of willpower. Avoid driving when sleepy, arrange another way to travel and tell a clinician promptly what happened. AASM's public safety guidance connects excessive sleepiness with impaired performance and recommends reporting ineffective treatment. Its commercial-driver certification rules are specific to that setting; this article does not issue a return-to-driving clearance. A better device number or a few better mornings cannot by itself establish safe alertness for the next journey.

FAQs: Sleep Disorders, Fatigue, and Professional Operators Sleep Apnea — What Is Sleep Apnea?

Get appropriate care for urgent symptoms

This is a reading companion, not a diagnosis, device prescription, or sleep-lab visit. Witnessed breathing pauses, gasping, crashing daytime sleepiness, or unrefreshing sleep after a full-looking night belong with a qualified clinician. Chest pain, fainting, one-sided weakness, or sudden breathlessness need emergency care. Do not start, stop, or change prescribed airway treatment from this text. This page does not treat one airway or promise an outcome.

Sleep Apnea — Symptoms Recognizing medical emergencies

Use the research as a reading companion

Named sources. Honest paraphrase of the finding. Not medical, legal, or financial advice.

References for this topic

Sources and context

Sleep Apnea — What Is Sleep Apnea? ↗
id
sleep-apnea--nhlbi-overview — Sleep Apnea — What Is Sleep Apnea?
kind
official
accessed at
2026-10-01
supports
Explains OSA and central apnea, airway interruption, sleep quality and daytime function.
limitations
Public education; does not diagnose one person or specify therapy settings.
original id
nhlbi-overview
Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea ↗
id
sleep-apnea--aasm-diagnosis — Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea
kind
guideline
accessed at
2026-10-01
supports
Kapur et al. 2017 covers clinical evaluation, laboratory versus home-test selection, relevant coexisting conditions, negative or inconclusive home-test follow-up and hypopnea definitions.
limitations
Adult clinician guideline. This article draws on its recommendations and discussion of methods; the evidence tables have not been independently reanalyzed.
original id
aasm-diagnosis
The occurrence of sleep-disordered breathing among middle-aged adults ↗
id
sleep-apnea--young-prevalence — The occurrence of sleep-disordered breathing among middle-aged adults
kind
study
accessed at
2026-10-01
supports
Young et al. 1993 studied 602 randomly sampled employed adults aged 30–60 in a sleep laboratory and found substantial unrecognized breathing disturbance in women and men.
limitations
This summary draws on the PubMed abstract. The historical Wisconsin sample and scoring rules do not establish current national prevalence or treatment effectiveness.
original id
young-prevalence
Increased prevalence of sleep-disordered breathing in adults ↗
id
sleep-apnea--peppard-prevalence — Increased prevalence of sleep-disordered breathing in adults
kind
study
accessed at
2026-10-01
supports
Peppard et al. 2013 modeled prevalence using 1,520 Wisconsin participants aged 30–70, with age, sex and BMI estimates applied to NHANES distributions.
limitations
This summary draws on the primary abstract; the full text was not inspected. Historical prevalence estimates do not give a person's present diagnostic probability or show an intervention's effect.
original id
peppard-prevalence
Sleep Apnea — Symptoms ↗
id
sleep-apnea--nhlbi-symptoms — Sleep Apnea — Symptoms
kind
official
accessed at
2026-10-01
supports
Describes witnessed pauses, gasping, sleepiness, fatigue, headache, insomnia and nighttime urination as symptoms to discuss with a clinician.
limitations
Symptoms overlap other conditions; adult teaching here does not apply pediatric management.
original id
nhlbi-symptoms
Sleep Apnea — Sleep Apnea and Women ↗
id
sleep-apnea--nhlbi-women — Sleep Apnea — Sleep Apnea and Women
kind
official
accessed at
2026-10-01
supports
Explains menopause-related risk and symptoms that overlap with insomnia, fatigue and headache.
limitations
General population information, not diagnosis from age, sex or reproductive stage.
original id
nhlbi-women
Sonia Ancoli-Israel — UCSD Profiles ↗
id
sleep-apnea--ancoli-profile — Sonia Ancoli-Israel — UCSD Profiles
kind
professional
accessed at
2026-10-01
supports
Documents sleep and behavioral-sleep certifications, education awards, and research on sleep-disordered breathing in older adults.
limitations
Professional contribution context, not evidence diagnosing fatigue in an older adult.
original id
ancoli-profile
Sleep Apnea — Diagnosis ↗
id
sleep-apnea--nhlbi-diagnosis — Sleep Apnea — Diagnosis
kind
official
accessed at
2026-10-01
supports
Explains the role of medical history, risk factors, sleep studies, a diary and medicine review.
limitations
No self-diagnosis, mandatory diary duration or personal test order.
original id
nhlbi-diagnosis
FAQs: Sleep Disorders, Fatigue, and Professional Operators ↗
id
sleep-apnea--aasm-safety — FAQs: Sleep Disorders, Fatigue, and Professional Operators
kind
professional
accessed at
2026-10-01
supports
Explains AHI versus REI, the monitoring-time denominator, unmeasured arousals, device estimates, leak and drowsy-driving precautions.
limitations
Occupational focus; certification thresholds and restrictions are not generalized to all adults.
original id
aasm-safety
Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline ↗
id
sleep-apnea--aasm-pap — Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline
kind
guideline
accessed at
2026-10-01
supports
Patil et al. 2019 gives a strong recommendation for sleepiness and conditional recommendations for quality of life and hypertension. It also covers CPAP/APAP, starting treatment at home or in a laboratory, education, troubleshooting and monitoring.
limitations
Publisher preview; subscription full text not inspected. Not a pressure-setting guide or universal cardiovascular-prevention claim.
original id
aasm-pap
Clinical Practice Guideline for the Treatment of Obstructive Sleep Apnea and Snoring with Oral Appliance Therapy: An Update for 2015 ↗
id
sleep-apnea--aasm-oral — Clinical Practice Guideline for the Treatment of Obstructive Sleep Apnea and Snoring with Oral Appliance Therapy: An Update for 2015
kind
guideline
accessed at
2026-10-01
supports
Ramar et al. describes custom adjustable appliances, CPAP intolerance or treatment preference, dental oversight, bite effects and follow-up testing.
limitations
Adult treatment guidance; publisher preview rather than full evidence review. Not every mouthguard or every patient's preferred treatment.
original id
aasm-oral
Sleep Apnea — Living With ↗
id
sleep-apnea--nhlbi-living — Sleep Apnea — Living With
kind
official
accessed at
2026-10-01
supports
Covers PAP during all sleep, including naps, along with travel, mask leak, comfort and clinical follow-up.
limitations
Does not establish a universal number of hours or routine repeat-study schedule.
original id
nhlbi-living
Obstructive Sleep Apnea in Adults: Screening ↗
id
sleep-apnea--uspstf-screening — Obstructive Sleep Apnea in Adults: Screening
kind
guideline
accessed at
2026-10-01
supports
Explains the 2022 I statement, the inclusion of unrecognized symptoms, the exclusion of people presenting with concerns, and differences from targeted-screening recommendations.
limitations
Adult primary-care screening; not symptomatic diagnostic evaluation, pregnancy, children or occupational fitness rules.
original id
uspstf-screening
Clinical Guideline for the Evaluation, Management and Long-term Care of Obstructive Sleep Apnea in Adults ↗
id
sleep-apnea--aasm-adult-management — Clinical Guideline for the Evaluation, Management and Long-term Care of Obstructive Sleep Apnea in Adults
kind
guideline
accessed at
2026-10-01
supports
Explains assessment and management across several aspects of OSA. The common severity thresholds in this article are also supported by USPSTF definitions.
limitations
Historical guideline; newer topic-specific recommendations take precedence. The publisher abstract and recommendations were accessible, but a readable full severity table was not available.
original id
aasm-adult-management
Polysomnography for Obstructive Sleep Apnea Should Include Arousal-Based Scoring: An American Academy of Sleep Medicine Position Statement ↗
id
sleep-apnea--aasm-arousal-scoring — Polysomnography for Obstructive Sleep Apnea Should Include Arousal-Based Scoring: An American Academy of Sleep Medicine Position Statement
kind
guideline
accessed at
2026-10-01
supports
Explains arousal-based versus oxygen-only hypopnea scoring, the 3%/arousal versus 4% rules and why home testing may miss arousal-related events.
limitations
This summary draws on the publisher abstract. A scoring position statement does not provide independent evidence of treatment benefit.
original id
aasm-arousal-scoring
Sleep Apnea — Treatment ↗
id
sleep-apnea--nhlbi-treatment — Sleep Apnea — Treatment
kind
official
accessed at
2026-10-01
supports
Explains PAP modes, oral devices, lifestyle measures and how selected operations work.
limitations
Broad patient education; clinical indications and device settings need individual assessment.
original id
nhlbi-treatment
Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning ↗
id
sleep-apnea--weaver-use — Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning
kind
study
accessed at
2026-10-01
supports
Weaver et al. 2007 followed adults with severe OSA for three months in a multicenter, quasi-experimental study, examining how longer CPAP use related to different outcomes.
limitations
This summary draws on the primary abstract; the full text was not inspected. The observed use-response associations do not establish a universal safety threshold or the result of randomly assigning hours of use.
original id
weaver-use
Use of polysomnography and home sleep apnea tests for the longitudinal management of obstructive sleep apnea in adults: an American Academy of Sleep Medicine clinical guidance statement ↗
id
sleep-apnea--aasm-followup — Use of polysomnography and home sleep apnea tests for the longitudinal management of obstructive sleep apnea in adults: an American Academy of Sleep Medicine clinical guidance statement
kind
guideline
accessed at
2026-10-01
supports
Caples et al. 2021 gives six follow-up statements: routine repeat studies are unnecessary for asymptomatic PAP users, while non-PAP treatment response, recurrent symptoms, weight or cardiovascular changes and unexplained device data can warrant testing.
limitations
Clinician guidance with expert opinion; does not mandate the same test/timing for every change.
original id
aasm-followup
FDA Approves First Medication for Obstructive Sleep Apnea ↗
id
sleep-apnea--fda-tirzepatide — FDA Approves First Medication for Obstructive Sleep Apnea
kind
official
accessed at
2026-10-01
supports
The December 20, 2024 approval concerns OSA in adults with obesity alongside lifestyle measures. It describes 469 adults without type 2 diabetes in two 52-week trials, contraindications and adverse effects.
limitations
Historical approval announcement, not a claim about the number of approved medicines in October 2026. Current individual prescribing needs current label review.
original id
fda-tirzepatide
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity ↗
id
sleep-apnea--surmount-osa — Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity
kind
study
accessed at
2026-10-01
supports
Malhotra et al. 2024 reports randomized trials, starting AHI/BMI, between-group AHI differences at 52 weeks, gastrointestinal effects and Eli Lilly funding.
limitations
This summary draws on the primary abstract and its results. The trial population and one-year endpoints do not establish a universal cure, a dosing instruction or cardiovascular-event prevention. The publication links an erratum; any changes in inaccessible full text have not been reviewed.
original id
surmount-osa
Obstructive Sleep Apnea Screening Health Advisory ↗
id
sleep-apnea--aasm-screening-advisory — Obstructive Sleep Apnea Screening Health Advisory
kind
professional
accessed at
2026-10-01
supports
Advises annual screening in selected high-risk groups, including people with heart failure, elevated or resistant blood pressure, atrial fibrillation, type 2 diabetes or stroke.
limitations
Health advisory, distinct evidence threshold from a population-screening systematic review.
original id
aasm-screening-advisory
CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea ↗
id
sleep-apnea--save-trial — CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea
kind
study
accessed at
2026-10-01
supports
McEvoy et al. 2016 studied 2,717 adults with OSA and established cardiovascular disease. Average CPAP use was 3.3 hours nightly over 3.7 years; the main combined event outcome did not improve significantly, while symptoms and quality of life did.
limitations
This summary draws on the complete primary abstract, not the full text. Participants were mostly minimally sleepy men with existing disease; the intention-to-treat result under observed use does not settle every population or pattern of use.
original id
save-trial
Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association ↗
id
sleep-apnea--aha-cardiovascular — Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association
kind
guideline
accessed at
2026-10-01
supports
Yeghiazarians et al. 2021 discusses OSA's relevance to cardiovascular evaluation and care.
limitations
This summary draws on the complete primary abstract, not the full text. Associations discussed in a scientific statement do not establish guaranteed prevention by PAP.
original id
aha-cardiovascular
Referral of adults with obstructive sleep apnea for surgical consultation: an American Academy of Sleep Medicine clinical practice guideline ↗
id
sleep-apnea--aasm-surgery — Referral of adults with obstructive sleep apnea for surgical consultation: an American Academy of Sleep Medicine clinical practice guideline
kind
guideline
accessed at
2026-10-01
supports
Kent et al. 2021 describes surgical-referral discussions for PAP intolerance or nonacceptance, BMI criteria for sleep and bariatric referrals, and initial PAP treatment when major anatomic abnormalities are present.
limitations
A referral discussion is not a recommendation to undergo an operation. This article uses the final published guideline, not the 2020 draft.
original id
aasm-surgery
Sleep Apnea Notification Feature (SANF) — FDA 510(k) Summary K240929 ↗
id
sleep-apnea--fda-watch-notification — Sleep Apnea Notification Feature (SANF) — FDA 510(k) Summary K240929
kind
official
accessed at
2026-10-01
supports
Defines notifications for possible moderate-to-severe apnea in previously undiagnosed adults. The feature does not diagnose or manage apnea, and absence of a notification does not establish absence of apnea.
limitations
Device-specific regulatory record, not authorization of all watches or a substitute for clinical diagnosis.
original id
fda-watch-notification
Apple Watch has warned me about possible sleep apnea for 3 months straight. Has anyone else experienced this? ↗
id
sleep-apnea--wearable-question — Apple Watch has warned me about possible sleep apnea for 3 months straight. Has anyone else experienced this?
kind
question_signal
accessed at
2026-10-01
supports
A public question about repeated possible-apnea notifications illustrates why readers need to distinguish a general sleep score, a notification and diagnostic testing.
limitations
Unverified anonymous experience; comments and agreement do not establish device performance, diagnosis, prevalence or treatment benefit.
original id
wearable-question
Recognizing medical emergencies ↗
id
sleep-apnea--medical-emergencies — Recognizing medical emergencies
kind
official
accessed at
2026-10-01
supports
Explains when chest symptoms, breathing difficulty, loss of consciousness and sudden weakness need emergency care.
limitations
General emergency information; not a claim that these signs are caused by OSA.
original id
medical-emergencies

Professional perspectives

Paul E. Peppard
PhD in Epidemiology; Professor, Population Health Sciences, UW–Madison
Public usefulness
Official biography explains obesity, sleep-disorder predictors and population consequences; his prevalence paper helps explain why apnea is an ordinary adult-health question.
Contribution
2013 modeled prevalence update and the distinction between population estimates and one person's sleep test.
Scope and limits
Historical prevalence modeling cannot diagnose an individual or establish weight loss as a guaranteed cure.
Reviewed
2026-10-01
Susan Redline
MD, MPH; Harvard-affiliated sleep researcher, verified in NHLBI workshop participant record
Public usefulness
Named speaker in public NHLBI sleep/blood-pressure education and coauthor of the SURMOUNT-OSA publication opened here.
Contribution
Population and trial perspectives on sleep-related cardiovascular questions, measurement and applicability.
Scope and limits
The workshop documents her role and public teaching, not an individual risk forecast. The separate Harvard role page was not accessible.
Reviewed
2026-10-01
Atul Malhotra
Professor of Medicine, UC San Diego; lead investigator/author of the SURMOUNT-OSA paper
Public usefulness
Official profile exposes airway-mechanics research and public publications explaining why different OSA treatments fit different mechanisms.
Contribution
Tirzepatide trial findings and distinction between treating a defined population and promising a cure to everyone.
Scope and limits
Professor role verified directly; trial abstract used for medical findings. Industry-funded trial participation does not make every treatment claim independent.
Reviewed
2026-10-01
Naresh M. Punjabi
MD, PhD; sleep physician and epidemiologist, qualifications documented in FDA-hosted curriculum vitae
Public usefulness
CV documents invited education on apnea physiology, diagnosis, cardiometabolic effects and Sleep Heart Health Study findings.
Contribution
Connects daytime function and cardiometabolic outcomes to the study population and research method.
Scope and limits
The 2023 CV documents a historical professional role, not his latest administrative title or a personal prognosis.
Reviewed
2026-10-01
Nancy Collop
MD; former AASM president and Emory sleep specialist as documented by AASM
Public usefulness
Professional-society public announcement records her sleep education and standards role; diagnostic guidance supplies the factual rules rather than her title.
Contribution
Clinical selection and oversight of home testing, rather than treating a portable monitor as a retail diagnosis.
Scope and limits
The 2011 announcement documents a historical role, not a current presidency. The former Emory link no longer supplied an individual biography.
Reviewed
2026-10-01
Susheel P. Patil
MD, PhD; University Hospitals sleep physician; lead author of 2019 AASM PAP guideline
Public usefulness
Official clinician-education articles discuss OSA care and research; public guideline states treatment recommendations and follow-up requirements.
Contribution
Distinguishes recommendations for sleepiness, quality of life and hypertension, and includes education and troubleshooting in treatment.
Scope and limits
A guideline is not a brand recommendation, pressure prescription or guarantee of cardiovascular prevention.
Reviewed
2026-10-01
Terri E. Weaver
PhD, RN; Dean and Professor Emerita, University of Illinois Chicago College of Nursing
Public usefulness
Official biography explains her Functional Outcomes of Sleep Questionnaire and international treatment-outcome education.
Contribution
Connects nightly treatment use to daytime sleepiness and functioning, including the practical ability to use treatment.
Scope and limits
The use-response study is quasi-experimental and does not establish a universally sufficient number of hours.
Reviewed
2026-10-01
Allan I. Pack
MBChB, PhD; University of Pennsylvania sleep researcher, verified in publisher author information
Public usefulness
Named author of the public professional editorial Sleep Medicine: Strategies for Change; contributor to PAP-use research cited in the opened guideline.
Contribution
Explains care delivery and treatment use in everyday life, including what happens after a device is supplied.
Scope and limits
The author information documents a historical affiliation; the Penn faculty page was not accessible. Editorial authorship does not establish treatment effectiveness.
Reviewed
2026-10-01
Sonia Ancoli-Israel
PhD; Professor Emeritus of Psychiatry and Professor of Research, UC San Diego; certified in sleep and behavioral sleep medicine
Public usefulness
Official profile documents education recognition and longstanding sleep, aging and apnea research, including an aged-population prevalence program.
Contribution
Addresses sleep symptoms in older adults and the need to consider explanations beyond inevitable aging.
Scope and limits
Professional contribution establishes relevance, not that every older adult's fatigue is apnea.
Reviewed
2026-10-01
Clete A. Kushida
MD, PhD; Stanford Professor and Chief of the Division of Sleep Medicine
Public usefulness
Official biography records sleep-teaching programs, textbooks, PAP trials and standards leadership.
Contribution
Explains objective treatment evaluation and the range of sleep and airway questions involved in OSA care.
Scope and limits
Trial and teaching leadership are not a personal titration or surgery plan; final 2021 surgery guideline supplies referral criteria.
Reviewed
2026-10-01
Daniel J. Gottlieb
MD, MPH; coauthor of 2021 AASM surgical-referral guideline, with VA Boston/Brigham affiliation documented at publication
Public usefulness
Public guideline translates treatment-selection evidence into referral discussions; official publisher verifies qualifications.
Contribution
Places alternative treatments within a comprehensive care decision without promising cardiovascular protection.
Scope and limits
The guideline documents his role at publication. The Harvard page was not accessible, so a current biography has not been verified.
Reviewed
2026-10-01
Reena Mehra
MD, MS; tenured Professor, Division of Pulmonary, Critical Care and Sleep Medicine, University of Washington
Public usefulness
UW faculty/research pages document multicenter sleep research and mentoring; UW publicly lists a 2026 Sleep Apnea and Arrhythmias teaching session.
Contribution
Connects cardiovascular and sleep concerns with the clinical interpretation of diagnosed OSA.
Scope and limits
The listed affiliation is with the University of Washington. A faculty role or teaching session does not demonstrate that PAP prevents every arrhythmia.
Reviewed
2026-10-01
Vishesh K. Kapur
MD, MPH; UW Medicine Sleep Center founder and lead author of 2017 AASM diagnostic-testing guideline
Public usefulness
Official research page explains epidemiology, guideline development and home-versus-laboratory care research; UW lists public sleep-disordered-breathing teaching.
Contribution
Explains clinical test selection, the meaning of a negative home test and the importance of scoring definitions.
Scope and limits
Guideline applies to clinicians' adult evaluation, not a consumer wearable score or personal test order.
Reviewed
2026-10-01
Kannan Ramar
MBBS, MD; lead author, AASM/AADSM oral-appliance guideline; Mayo Clinic affiliation documented at publication
Public usefulness
Public society guideline offers a clear route from treatment preference/intolerance to custom fitting and verified response.
Contribution
Distinguishes supervised oral-appliance care from generic snoring guards, including dental and sleep follow-up.
Scope and limits
Publication-era credential/role verified; guideline does not say every individual will respond to an appliance.
Reviewed
2026-10-01
Leslie C. Dort
DDS; dental coauthor, AASM/AADSM oral-appliance guideline; University of Calgary affiliation documented at publication
Public usefulness
Public guideline brings qualified dental oversight, bite changes and titratable devices into the ordinary treatment conversation.
Contribution
Explains dental effects and long-term fit alongside the breathing effects of mandibular advancement.
Scope and limits
Coauthorship verifies a specific contribution; it is not an endorsement of a retail appliance or a personal dental consultation.
Reviewed
2026-10-01
David Kent
MD; lead author, 2021 AASM surgical-referral guideline; Vanderbilt affiliation documented at publication
Public usefulness
Final public guideline explains who should discuss surgical consultation and why a referral is different from selecting an operation.
Contribution
Explains when PAP intolerance or nonacceptance supports a discussion of surgical referral and which selection criteria apply.
Scope and limits
Guideline recommendation is to discuss referral; risks, anatomy, residual disease and a person's preferences remain individual questions.
Reviewed
2026-10-01

Keep this topic in view

Preserved original record

The earlier public profile is preserved separately from the current article. It may contain superseded wording and is not newly checked material.

Read the full original profile

slug

sleep-apnea

name

Sleep apnea

browse Line

Understand why snoring with breathing pauses and unrefreshing sleep deserve assessment.

photo

/learn/assets/topics/sleep-apnea.jpg

photo Alt

An adult sitting on the edge of a made bed in morning light, looking toward a window

aliases

OSA
obstructive sleep apnea
CPAP
snoring pauses
AHI
home sleep test
sleep study
apnea hypopnea

family

body

heat

mid

talk

Sources

most Discussed

true

first Line

Obstructive sleep apnea is repeated narrowing or blockage of the upper airway during sleep, which disrupts breathing and can fragment sleep. Understanding the symptoms, sleep-test measurements and treatment options helps explain why a full night in bed may still leave someone unrefreshed.

why Line

feel Words

snore
pause
gasp
choke
witnessed apnea
unrefreshed
daytime sleepiness
crash

common Picture

lead
Bring witnessed pauses and gasping to a clinician
why
Obstructive sleep apnea means the upper airway keeps collapsing during sleep, which can show up as snoring, pauses, gasping, or a partner's shove. NHLBI public guidance treats witnessed pauses, gasping, and crashing daytime sleepiness as reasons to talk with a clinician rather than waiting for a perfect week. Terry Young's Wisconsin Sleep Cohort measured this pattern in middle-aged adults outside a specialty-only sample, which is why ordinary snoring with pauses is a medical question. A page cannot watch your airway overnight. Write what a partner heard and how the next day feels, then bring that picture to a visit.
lead
Get help when a full-looking night still leaves you unrefreshed
why
Unrefreshing sleep after enough time in bed has many causes, including insomnia, depression, medicines, and circadian timing. Obstructive sleep apnea is one of the causes that a sleep study can look for when snoring, pauses, or high sleepiness are also in the story. Susan Redline's epidemiologic work treats sleep-disordered breathing as a population health pattern, not a rare clinic curiosity. USPSTF does not tell clinicians to screen every quiet, asymptomatic adult, which is different from evaluating someone who is already sleepy or gasping. If you cannot stay awake in meetings or while driving, say so in the first sentence. That is a safety fact, not a personality flaw.
lead
Ask which sleep test fits the question
why
Sleep testing measures breathing events as well as the context needed to interpret them. In a laboratory study, AHI counts apneas and hypopneas per hour actually asleep. Many home tests instead report REI per hour of monitoring, which can include awake time and underestimate event frequency. Common adult severity bands begin at 5, 15 and 30 events per hour, but symptoms, oxygen changes and scoring rules also matter. Ask what measurement your report uses and what happens if a home result is negative or inconclusive while the symptoms continue.
lead
Match treatment to the test result and to what you can use
why
Treatment aims to keep breathing open during sleep and improve the outcomes that matter, such as daytime alertness. PAP supports the airway with air pressure; a custom oral appliance holds the lower jaw forward. Ramar's guideline includes adults who cannot tolerate CPAP or prefer another approach, with dental oversight and follow-up testing. Weight management can be part of the plan, and additional medical or surgical options depend on the findings. Report what prevents regular use: leak, discomfort, dryness or continuing symptoms. A treatment's practical fit matters alongside its effect on the sleep study.

situation Quick Answers

- label
  What raises concern
  value
  Snoring with witnessed pauses, gasping or marked daytime sleepiness warrants evaluation.
- label
  Useful detail
  value
  Describe what happens overnight and how alert you feel the following day.
- label
  Why hours can mislead
  value
  Enough time in bed does not ensure uninterrupted breathing or restorative sleep.
- label
  Safety first
  value
  Say immediately if you cannot stay awake while driving; avoid driving when sleepy.
- label
  Test choice
  value
  Lab and home tests collect different information; the right choice depends on the history.
- label
  If home is unclear
  value
  A negative, inconclusive or poor-quality home test can require an in-lab study.
- label
  How they work
  value
  PAP supports the airway with air pressure; an oral appliance advances the lower jaw.
- label
  Follow-up
  value
  Effectiveness, comfort and regular use all need checking after treatment starts.

picture Lead

Bring witnessed pauses and gasping to a clinician

watch For

what People Say

Treat obstructive sleep apnea as a counted breathing pattern. Obstructive sleep apnea is repeated upper-airway collapse during sleep, often summarized with an apnea-hypopnea index plus symptoms such as sleepiness or gasping. NHLBI explains the pattern in public language as pauses, shallow breaths, and broken sleep. Young's Wisconsin Sleep Cohort showed that this is common in middle-aged adults, not only in people who already sit in sleep clinics. A count without a clinician's reading is not a home diagnosis. Bring the night story and the day story together.
Use a sleep test rather than a wearable score. AASM diagnostic guidance treats polysomnography and selected home sleep apnea tests as the ways to establish OSA, chosen by pretest probability and comorbidity. Kapur's guideline text is the named map for that choice. Consumer rings and watches can raise a useful question about restless nights. They do not replace an AHI scored with a defined hypopnea rule. Collop's portable-testing work likewise sits inside clinical selection, not inside a checkout page. Ask which test answers your question.
PAP keeps the airway open while it is used. Positive airway pressure delivers air through a mask to support the airway during sleep. Patil's 2019 AASM guideline strongly recommends PAP for adults with OSA and excessive sleepiness; it conditionally recommends it for impaired sleep-related quality of life or hypertension. Severity remains part of clinical assessment, but those are the guideline's stated recommendation groups. Mask comfort, leak and regular use affect whether the treatment can help. Pressure mode and follow-up are matched to the person rather than borrowed from somebody else's settings.
An oral appliance needs a fit and a check of whether it works. Ramar's AASM/AADSM guideline supports oral appliances for adults with OSA who cannot tolerate CPAP or prefer an alternative. It favors a custom, adjustable device fitted by a qualified dentist. Advancing the lower jaw can help keep the airway open, but comfort alone does not establish that breathing events are controlled. Dental follow-up and a sleep test after adjustment check both adverse effects and treatment effectiveness. An ordinary snoring guard does not provide the same evidence or follow-up process.
Read screening guidance as a limit on silent checklists. The 2022 USPSTF statement found insufficient evidence to recommend for or against screening adults who do not have recognized symptoms of OSA. That is an I statement, not a claim that OSA is rare. It is also not a bar on evaluating someone who already snores with pauses, gasps, or cannot stay awake. Gottlieb's cardiovascular-sleep work is one reason symptomatic people still deserve a pathway. Use symptoms and risk to start a visit. Do not wait for a universal workplace sniff test.
Treat sleepiness on the road as a safety fact. NHLBI and AASM patient education both treat drowsy driving and unintended sleep as reasons to seek care promptly, not as a joke about coffee. Punjabi's outcomes research links sleep-disordered breathing with daytime function and later health, which is why sleepiness is part of the clinical picture rather than an afterthought. If you have nodded at a light or on a highway, say that first. Treatment decisions still belong with a clinician. Uncontrolled sleepiness needs assessment before driving.

disputed Notes

Choose the sleep test for the clinical question. AASM guidance allows home testing for selected uncomplicated adults with signs suggesting moderate-to-severe OSA. It recommends an in-lab study for significant heart or lung disease, suspected hypoventilation and several other conditions that require broader monitoring. A negative, inconclusive or technically inadequate home test should be followed by polysomnography. This is more specific than a preference for one setting. A useful question is whether the chosen test can answer the breathing and sleep questions raised by the history, and what follow-up is planned if it cannot.
Treat weight change as helpful for some, not as a stand-in for moderate-severe care. Weight reduction can lower AHI in some adults, which epidemiologic work from Peppard and clinical teaching from Malhotra both keep in view. AASM still recommends treating OSA that is already moderate or severe rather than waiting for a target weight. Lifestyle work can sit beside PAP or an oral appliance. It should not be sold as a cure that lets a sleepy driver skip evaluation. Shared plans belong with a clinician who can see both the airway and the metabolic picture.
Match surgery talk to anatomy and to failed first-line care. Kushida and others have described surgical options for selected anatomy after evaluation, including when PAP cannot be used. Surgery is not first-line for typical garden-variety OSA in AASM treatment order. Some surgeons and some patients prefer an operation earlier; sleep-medicine guidance is more conservative. The live disagreement is sequence and selection, not whether anatomy can matter. Get a sleep-medicine opinion before treating a social-media before-and-after as a protocol.
Treat auto-adjusting PAP as a tool, not as set-and-forget. Auto-adjusting devices can fit many adults and reduce some titration visits, which Patil's guideline discusses among PAP modes. Weaver's adherence research still finds that mask leak, pressure intolerance, and nasal symptoms stop people from using the tool. Some clinicians prefer a fixed pressure after a titration night. The disagreement is how much remote data can replace a conversation. Follow-up is part of the treatment. A shipped box is not.

talk Notes

Treat loud snoring with pauses as a medical question. A common saying is that snoring is only a nuisance. NHLBI lists pauses, gasping, and daytime sleepiness as reasons to seek care. Young's cohort measured how often the pattern sits in ordinary adults. A partner's recording can help a visit. It cannot replace a scored test.
Use a wearable as a prompt, not as an AHI. Rings and watches estimate motion and sometimes oxygen. AASM diagnosis still uses a defined breathing-event rule. Redline's research language keeps measurement attached to a protocol. Let a graph send you to a clinician. Do not let it finish the study.
Keep using prescribed airway treatment until a clinician changes it. Online talk sometimes treats a few better mornings as a reason to shelf the machine. Weaver's adherence work treats regular use as the way the treatment can work. Patil's guideline is a treatment recommendation, not a weekend challenge. Ask before stopping.
Ask for evaluation even if you are not a stereotypical patient. Older cartoons treated OSA as only older heavy men who snore. Peppard's later prevalence work and Redline's cohort teaching show a wider adult picture, including women who may present with fatigue more than comedy snoring. NHLBI still wants symptomatic people assessed. A stereotype is not a screening rule.

how People Run It

Bring one night-and-day picture to a clinician. Write four short lines: what a partner heard, how sleepy the next day is, whether you gasp or wake choking, and whether driving or work is already unsafe. NHLBI and AASM both start with that story rather than with a wearable score. Collop's testing work is a reminder to ask which study fits after the history. This is ordinary preparation. It is not a diagnosis and not an order for a machine.
Record the available night and daytime pattern. Note snoring, witnessed pauses, morning headache, naps and any drowsy driving, including what a partner has observed. A sleep diary can help explain the pattern, but completing a set number of days is not a prerequisite for care. Seek prompt help for safety-relevant sleepiness rather than waiting to finish a two-week log.
Ask which test and which treatment you would actually use. If a study is offered, ask whether it is in-lab or home and what happens if OSA is found. Patil and Ramar name PAP and oral appliances as documented options. Weaver's point is usability. A plan you cannot use is not a plan.
Say so immediately if you have nodded off while driving. Unintended sleep in a car is a safety emergency for the next trip, not a personality joke. NHLBI and Punjabi's outcomes work keep sleepiness attached to real-world risk. Get clinical help before the next long drive when that has already happened.

how People Keep It

Keep OSA as a scored breathing diagnosis. AHI plus symptoms is the usual clinical language. Kapur's AASM diagnostic map and NHLBI public pages both protect that. A neck size or a snore app is not the diagnosis.
Review what PAP is improving and what makes it difficult to use. PAP is a major OSA treatment, especially when sleepiness is a problem. Bring mask leaks, dryness, discomfort or continuing symptoms to follow-up; these can affect regular use and the treatment's benefit.
Keep oral appliances inside dental-sleep care. Ramar's statement is about custom, titratable devices after evaluation. Pack's teaching keeps dentistry in the loop. A drugstore guard is not the researched appliance.
Separate screening uncertainty from symptoms that need assessment. USPSTF found insufficient evidence to judge routine screening in adults without recognized symptoms. This is not a recommendation against evaluating witnessed pauses, gasping or disruptive daytime sleepiness.
Keep a clinician in the loop when nights stay broken. Ancoli-Israel's older-adult sleep work is a reminder that unrefreshing sleep has more than one cause. Recheck if sleepiness, driving, or blood pressure care changes. A later appointment is ordinary.

claims Notes

Bring witnessed pauses and gasping to a clinician. Claim: “Loud snoring with breathing pauses is a reason to seek clinical evaluation” — established. NHLBI public guidance treats pauses, gasping, and daytime sleepiness as reasons to talk with a clinician. Young's cohort showed the pattern is common in ordinary adults. A page still cannot diagnose you.
Use a sleep test rather than a wearable score. Claim: “A wearable sleep score can diagnose obstructive sleep apnea” — not what the research found. AASM diagnostic guidance uses polysomnography or selected home sleep apnea tests with defined breathing-event rules. Consumer scores can raise a useful question about restless nights. They are not the diagnostic test and cannot replace a clinician-ordered study.
Treat PAP as first-line care for many moderate-severe cases. Claim: “PAP is first-line treatment for many adults with moderate or severe OSA” — established. PAP is a major treatment for OSA. Patil's 2019 AASM guideline strongly recommends it for excessive sleepiness, with conditional recommendations for impaired sleep-related quality of life or hypertension. Mask fit and follow-up remain part of care.
Keep weight change beside treatment rather than instead of it. Claim: “Losing weight always replaces the need to treat moderate-severe OSA” — not what the research found. Weight change can lower AHI for some people, which Peppard's epidemiology keeps in view. AASM still recommends treating moderate-severe OSA rather than waiting on a target weight while sleepiness continues.
Use symptoms and risk to start a visit, not a silent checklist. Claim: “Every adult should be screened for OSA even with no symptoms” — not what the research found. USPSTF 2022 found insufficient evidence to screen adults without recognized symptoms. That I statement is not a bar on evaluating gasping, pauses, or crashing sleepiness, which still belong with a clinician.
Ask about a custom oral appliance when PAP is not usable. Claim: “Custom oral appliances can be an option when PAP cannot be used” — established. Ramar's AASM statement supports custom mandibular-advancement devices for selected adults, including PAP-intolerant patients, with follow-up for residual events. A drugstore guard is not that researched device, and a dentist with sleep training still has to fit it.
Keep using prescribed airway treatment until a clinician changes it. Claim: “A few good nights mean you can stop prescribed PAP on your own” — popular talk. Weaver's adherence research treats regular use as how PAP can work. Patil's guideline is ongoing treatment, not a weekend challenge. Ask a clinician before stopping a prescribed device after a few better mornings.

deep Dive

Read Young 1993 as the community prevalence map. Terry Young, Palta, Dempsey, Skatrud, Weber, and Badr reported sleep-disordered breathing in a random sample of middle-aged adults, not only in people already referred to a lab. That paper is why snoring with pauses is treated as common enough to ask about. It is not a personal AHI and not a treatment trial. Bring your own night story to a clinician rather than borrowing a 1993 percentage.
Read Peppard 2013 as a later look at how common the pattern is. Paul Peppard and colleagues updated Wisconsin Sleep Cohort prevalence estimates and found sleep-disordered breathing remaining common. The paper is epidemiology, not a machine setting. Combined with Redline's broader cohort teaching, it supports asking ordinary adults about pauses and sleepiness. Group percentages still cannot diagnose one bedroom.
Read the test method before comparing two sleep-study numbers. Kapur's AASM guideline explains why event counts depend on both the sensors and scoring rule. A hypopnea can be scored using a fall in oxygen or an arousal, while another rule requires a larger oxygen fall. Many home tests cannot detect sleep stages or every arousal. Therefore, two reports can produce different numbers without either being a simple transcription error. Ask which event definition was used, whether time asleep was measured and whether signal quality was adequate. Those details make the result more understandable before treatment is discussed.
Use Patil 2019 as the PAP recommendation, with adherence attached. Patil's task force recommended PAP for OSA in adults after a systematic review of randomized and observational evidence on sleepiness, quality of life, and blood pressure among other outcomes. Weaver's research program treats hours of use as the practical limit on those benefits. A prescription without mask follow-up is an incomplete plan. Remote data can help. It does not replace a conversation about leak and comfort.
Use Ramar 2015 as the oral-appliance recommendation. Ramar's AASM and American Academy of Dental Sleep Medicine statement supports custom mandibular advancement for selected adults, with follow-up for residual events. It is not a consumer mouthguard trial. Pack's clinical teaching is why a dentist with sleep training and a sleep clinician often share the case. Repeat testing after titration is part of the method. A one-visit snap is not.
Read the USPSTF I statement as a screening limit. The 2022 USPSTF recommendation applies to adults without recognized signs or symptoms, and to people who do not report symptoms as a problem. It is not a rule against evaluating gasping, pauses, or crashing sleepiness. Gottlieb and Mehra's cardiovascular-sleep work still treat diagnosed OSA as relevant to heart and vascular conversations. Screening silence is not the same as treatment silence.
Keep cardiovascular talk attached to diagnosed OSA, not to a snore joke. Yeghiazarians and colleagues' American Heart Association scientific statement reviews links among OSA, hypertension, and cardiovascular disease for clinicians. Mehra's research program is one reason cardiology asks about sleep. Association is not a home prediction that a machine will prevent every event. Blood-pressure care still belongs with the treating clinician. Mention OSA in that visit when it has been diagnosed or strongly suspected.
Treat older-adult fatigue as a reason to look, not to shrug. Sonia Ancoli-Israel spent decades showing that sleep-disordered breathing in older adults is easy to miss when people call it normal aging. White's physiology teaching likewise separates sleepy from inevitable. NHLBI still wants unrefreshing sleep assessed. Aging is not a diagnosis of OSA and not a reason to skip the question. Bring the pattern, including medicines and nocturia, to the visit.
Weight-related OSA now has a studied medication option for a defined group. In December 2024, the FDA approved tirzepatide for moderate-to-severe OSA in adults with obesity, alongside dietary and activity changes. Two placebo-controlled trials followed 469 adults without type 2 diabetes for 52 weeks; one enrolled PAP users and the other people unable or unwilling to use PAP. Breathing-event frequency improved more with tirzepatide in both trials. This adds a treatment discussion for that population, rather than proving that any weight-loss product cures apnea. Side effects and contraindications require review, and an improvement in weight or snoring does not by itself establish that prescribed airway treatment can be stopped.

related

sleep
attention
fitness

watch For Long

Good to know. This is a reading companion, not a diagnosis, device prescription, or sleep-lab visit. Witnessed breathing pauses, gasping, crashing daytime sleepiness, or unrefreshing sleep after a full-looking night belong with a qualified clinician. Chest pain, fainting, one-sided weakness, or sudden breathlessness need emergency care. Do not start, stop, or change prescribed airway treatment from this text. This page does not treat one airway or promise an outcome.
Not advice. Named sources. Honest paraphrase of the finding. Not medical, legal, or financial advice.

sources

Terry Young, PhD. University of Wisconsin epidemiologist who led the Wisconsin Sleep Cohort's community prevalence work. Cohort percentages are not a personal AHI.
Paul E. Peppard, PhD. Wisconsin epidemiologist who updated adult sleep-disordered-breathing prevalence. Later percentages still cannot score one night.
Susan Redline, MD, MPH. Harvard sleep epidemiologist whose cohort work treats sleep-disordered breathing as population health. Cohorts are not a clinic visit.
Atul Malhotra, MD. UC San Diego sleep physician-researcher on OSA physiology and treatment. Physiology talks are not a mask fitting.
Naresh M. Punjabi, MD, PhD. sleep physician-epidemiologist studying outcomes of sleep-disordered breathing. Outcome studies are not a driving clearance.
Nancy Collop, MD. Emory sleep physician and past AASM president whose work shaped home-testing practice. Portable monitors still need selection.
Susheel P. Patil, MD, PhD. sleep physician who led the 2019 AASM PAP guideline. The statement is not a brand ranking.
Terri E. Weaver, PhD, RN. nurse scientist whose research treats PAP hours of use as the practical limit on benefit. Adherence work is not a scolding.
Allan I. Pack, MBChB, PhD. University of Pennsylvania sleep physician-researcher. Academic programs are not walk-in care from a page.
Sonia Ancoli-Israel, PhD. psychologist and sleep researcher who documented sleep-disordered breathing in older adults. Aging is not a diagnosis.
Clete A. Kushida, MD, PhD. Stanford sleep physician and AASM guideline leader. Society roles are not a surgical protocol for a visitor.
Daniel J. Gottlieb, MD, MPH. VA Boston and Harvard sleep physician-epidemiologist. Heart associations are not a personal event forecast.
Reena Mehra, MD, MS. Cleveland Clinic sleep physician-researcher on sleep and cardiovascular disease. Clinic pages are not a personal cardiology plan.
David P. White, MD. Harvard-affiliated sleep physician known for upper-airway physiology teaching. Physiology is not a mask brand.
Vishesh K. Kapur, MD, MPH. University of Washington sleep physician who led the 2017 AASM diagnostic-testing guideline. The map is for clinicians.

source Links

NHLBI-OSA

name

National Heart, Lung, and Blood Institute. Sleep Apnea public health page.

kind

evidence

links

label
NHLBI
href
https://www.nhlbi.nih.gov/health/sleep-apnea

YOUNG-1993

name

Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328(17):1230-1235.

kind

evidence

links

label
PubMed
href
https://pubmed.ncbi.nlm.nih.gov/8464434/

PEPPARD-2013

name

Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177(9):1006-1014.

kind

evidence

links

label
PubMed
href
https://pubmed.ncbi.nlm.nih.gov/23589584/

USPSTF-OSA-2022

name

US Preventive Services Task Force. Screening for Obstructive Sleep Apnea in Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2022;328(19):1945-1950.

kind

evidence

links

label
USPSTF
href
https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/obstructive-sleep-apnea-in-adults-screening

AASM-DIAG-2017

name

Kapur VK, Auckley DH, Chowdhuri S, et al. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(3):479-504.

kind

evidence

links

label
JCSM
href
https://jcsm.aasm.org/doi/10.5664/jcsm.6506

PATIL-PAP-2019

name

Patil SP, Ayappa IA, Caples SM, Kimoff RJ, Patel SR, Harrod CG. Treatment of adult obstructive sleep apnea with positive airway pressure: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2019;15(2):335-343.

kind

evidence

links

label
JCSM
href
https://jcsm.aasm.org/doi/10.5664/jcsm.7640

RAMAR-OA-2015

name

Ramar K, Dort LC, Katz SG, et al. Clinical practice guideline for the treatment of obstructive sleep apnea and snoring with oral appliance therapy: an update for 2015. J Clin Sleep Med. 2015;11(7):773-827.

kind

evidence

links

label
JCSM
href
https://jcsm.aasm.org/doi/10.5664/jcsm.4858

AHA-OSA-2021

name

Yeghiazarians Y, Jneid H, Tietjens JR, et al. Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2021;144(3):e56-e67.

kind

evidence

links

label
AHA
href
https://www.ahajournals.org/doi/10.1161/CIR.0000000000000988

AASM-PUBLIC

name

American Academy of Sleep Medicine. Public patient pages on obstructive sleep apnea, testing, and treatment.

kind

evidence

links

label
AASM
href
https://sleepeducation.org/sleep-disorders/obstructive-sleep-apnea/

MEHRA-SLEEP-CV

name

Mehra R. Sleep-disordered breathing and cardiovascular disease research and clinical education used here as named professional context for heart-sleep overlap.

kind

evidence

links

label
PubMed
href
https://pubmed.ncbi.nlm.nih.gov/?term=Mehra+R+sleep+apnea

YOUNG-OSA-2026

name

Terry Young, PhD

kind

professional

links

label
PubMed
href
https://pubmed.ncbi.nlm.nih.gov/8464434/

PEPPARD-OSA-2026

name

Paul E. Peppard, PhD

kind

professional

links

label
PubMed
href
https://pubmed.ncbi.nlm.nih.gov/23589584/

REDLINE-OSA-2026

name

Susan Redline, MD, MPH

kind

professional

links

label
Harvard
href
https://sleep.hms.harvard.edu/faculty-staff/susan-redline

MALHOTRA-OSA-2026

name

Atul Malhotra, MD

kind

professional

links

label
UCSD
href
https://providers.ucsd.edu/details/22280/pulmonary-critical-care-sleep-medicine

PUNJABI-OSA-2026

name

Naresh M. Punjabi, MD, PhD

kind

professional

links

label
PubMed
href
https://pubmed.ncbi.nlm.nih.gov/?term=Punjabi+NM+sleep

COLLOP-OSA-2026

name

Nancy Collop, MD

kind

professional

links

label
Emory
href
https://med.emory.edu/directory/profile/?u=NCOLLOP

PATIL-OSA-2026

name

Susheel P. Patil, MD, PhD

kind

professional

links

label
JCSM
href
https://jcsm.aasm.org/doi/10.5664/jcsm.7640

WEAVER-OSA-2026

name

Terri E. Weaver, PhD, RN

kind

professional

links

label
UIC
href
https://nursing.uic.edu/profiles/weaver-terri/

PACK-OSA-2026

name

Allan I. Pack, MBChB, PhD

kind

professional

links

label
Penn
href
https://www.med.upenn.edu/sleepctr/allan-i-pack-mbchb-phd.html

ANCOLI-OSA-2026

name

Sonia Ancoli-Israel, PhD

kind

professional

links

label
UCSD
href
https://profiles.ucsd.edu/sonia.ancoli-israel

KUSHIDA-OSA-2026

name

Clete A. Kushida, MD, PhD

kind

professional

links

label
Stanford
href
https://med.stanford.edu/profiles/clete-kushida

GOTTLIEB-OSA-2026

name

Daniel J. Gottlieb, MD, MPH

kind

professional

links

label
Harvard
href
https://sleep.hms.harvard.edu/faculty-staff/daniel-j-gottlieb

MEHRA-OSA-2026

name

Reena Mehra, MD, MS

kind

professional

links

label
PubMed
href
https://pubmed.ncbi.nlm.nih.gov/?term=Mehra+R+obstructive+sleep+apnea

WHITE-OSA-2026

name

David P. White, MD

kind

professional

links

label
Harvard
href
https://sleep.hms.harvard.edu/faculty-staff/david-p-white

KAPUR-OSA-2026

name

Vishesh K. Kapur, MD, MPH

kind

professional

links

label
JCSM
href
https://jcsm.aasm.org/doi/10.5664/jcsm.6506

NHLBI-OSA-CHECKED

name

NHLBI: Sleep Apnea. Source

kind

evidence

links

label
Source
href
https://www.nhlbi.nih.gov/health/sleep-apnea

KAPUR-2017-CHECKED

name

Kapur et al. AASM clinical practice guideline for diagnostic testing for adult OSA. Source

kind

evidence

links

label
Source
href
https://www.aasm.org/resources/clinicalguidelines/diagnostic-testing-osa.pdf

NHLBI-OSA-TREATMENT-CHECKED

name

NHLBI: Sleep Apnea Treatment. Source

kind

evidence

links

label
Source
href
https://www.nhlbi.nih.gov/health/sleep-apnea/treatment

RAMAR-2015-CHECKED

name

Ramar et al. AASM/AADSM oral appliance guideline. Source

kind

evidence

links

label
Source
href
https://www.aasm.org/resources/clinicalguidelines/oral_appliance-osa.pdf

AASM-REI-CHECKED

name

AASM: Sleep Disorders, Fatigue and Professional Operators FAQs. Source

kind

evidence

links

label
Source
href
https://aasm.org/advocacy/public-safety-faq/

PATIL-2019-CHECKED

name

Patil et al. Treatment of adult OSA with positive airway pressure. Source

kind

evidence

links

label
Source
href
https://pmc.ncbi.nlm.nih.gov/articles/6374094/

USPSTF-OSA-CHECKED

name

USPSTF: Obstructive Sleep Apnea in Adults, Screening. Source

kind

evidence

links

label
Source
href
https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/obstructive-sleep-apnea-in-adults-screening

NHLBI-OSA-DIAGNOSIS-CHECKED

name

NHLBI: Sleep Apnea Diagnosis. Source

kind

evidence

links

label
Source
href
https://www.nhlbi.nih.gov/health/sleep-apnea/diagnosis

FDA-OSA-TIRZEPATIDE-CHECKED

name

FDA Approves First Medication for Obstructive Sleep Apnea. Source

kind

evidence

links

label
Source
href
https://www.fda.gov/news-events/press-announcements/fda-approves-first-medication-obstructive-sleep-apnea

source Claims

watch For

NHLBI-OSA
USPSTF-OSA-2022
AASM-DIAG-2017

situations.snore-pause

NHLBI-OSA
YOUNG-1993
YOUNG-OSA-2026
NHLBI-OSA-CHECKED

situations.unrefreshed

REDLINE-OSA-2026
USPSTF-OSA-2022
NHLBI-OSA
NHLBI-OSA-CHECKED

situations.testing

AASM-DIAG-2017
COLLOP-OSA-2026
KAPUR-OSA-2026
KAPUR-2017-CHECKED
AASM-REI-CHECKED

situations.treatment

PATIL-PAP-2019
RAMAR-OA-2015
WEAVER-OSA-2026
PATIL-OSA-2026
NHLBI-OSA-TREATMENT-CHECKED
RAMAR-2015-CHECKED

split.established.0

NHLBI-OSA
YOUNG-1993
YOUNG-OSA-2026

split.established.1

AASM-DIAG-2017
KAPUR-OSA-2026
COLLOP-OSA-2026

split.established.2

PATIL-PAP-2019
PATIL-OSA-2026
MALHOTRA-OSA-2026
PATIL-2019-CHECKED
NHLBI-OSA-TREATMENT-CHECKED

split.established.3

RAMAR-OA-2015
PACK-OSA-2026
RAMAR-2015-CHECKED

split.established.4

USPSTF-OSA-2022
GOTTLIEB-OSA-2026

split.established.5

NHLBI-OSA
PUNJABI-OSA-2026
AASM-DIAG-2017

split.disputed.0

AASM-DIAG-2017
COLLOP-OSA-2026
KAPUR-OSA-2026
KAPUR-2017-CHECKED

split.disputed.1

PEPPARD-2013
PEPPARD-OSA-2026
MALHOTRA-OSA-2026
PATIL-PAP-2019

split.disputed.2

KUSHIDA-OSA-2026
PATIL-PAP-2019

split.disputed.3

PATIL-PAP-2019
WEAVER-OSA-2026
PATIL-OSA-2026

split.talk.0

NHLBI-OSA
YOUNG-1993

split.talk.1

AASM-DIAG-2017
REDLINE-OSA-2026

split.talk.2

WEAVER-OSA-2026
PATIL-PAP-2019

split.talk.3

PEPPARD-2013
REDLINE-OSA-2026
NHLBI-OSA

move

NHLBI-OSA
AASM-DIAG-2017
COLLOP-OSA-2026

try.0

YOUNG-1993
NHLBI-OSA
NHLBI-OSA-DIAGNOSIS-CHECKED

try.1

PATIL-PAP-2019
RAMAR-OA-2015
WEAVER-OSA-2026

try.2

NHLBI-OSA
PUNJABI-OSA-2026

keep.0

AASM-DIAG-2017
NHLBI-OSA
KAPUR-OSA-2026

keep.1

PATIL-PAP-2019
MALHOTRA-OSA-2026
PATIL-2019-CHECKED

keep.2

RAMAR-OA-2015
PACK-OSA-2026

keep.3

USPSTF-OSA-2022
GOTTLIEB-OSA-2026
USPSTF-OSA-CHECKED

keep.4

ANCOLI-OSA-2026
NHLBI-OSA

deep.0

YOUNG-1993
YOUNG-OSA-2026

deep.1

PEPPARD-2013
PEPPARD-OSA-2026
REDLINE-OSA-2026

deep.2

AASM-DIAG-2017
KAPUR-OSA-2026
COLLOP-OSA-2026
KAPUR-2017-CHECKED
AASM-REI-CHECKED

deep.3

PATIL-PAP-2019
PATIL-OSA-2026
WEAVER-OSA-2026

deep.4

RAMAR-OA-2015
PACK-OSA-2026

deep.5

USPSTF-OSA-2022
GOTTLIEB-OSA-2026
MEHRA-OSA-2026

deep.6

AHA-OSA-2021
MEHRA-OSA-2026

deep.7

ANCOLI-OSA-2026
WHITE-OSA-2026
NHLBI-OSA

deep.8

KUSHIDA-OSA-2026
WHITE-OSA-2026
FDA-OSA-TIRZEPATIDE-CHECKED

claims.0

NHLBI-OSA
YOUNG-1993

claims.1

AASM-DIAG-2017
KAPUR-OSA-2026

claims.2

PATIL-PAP-2019
PATIL-OSA-2026
PATIL-2019-CHECKED

claims.3

PEPPARD-2013
PATIL-PAP-2019

claims.4

USPSTF-OSA-2022

claims.5

RAMAR-OA-2015
PACK-OSA-2026

claims.6

WEAVER-OSA-2026
PATIL-PAP-2019

source Situation Keys

situations.snore-pause
situations.unrefreshed
situations.testing
situations.treatment

professional Source Ids

YOUNG-OSA-2026
PEPPARD-OSA-2026
REDLINE-OSA-2026
MALHOTRA-OSA-2026
PUNJABI-OSA-2026
COLLOP-OSA-2026
PATIL-OSA-2026
WEAVER-OSA-2026
PACK-OSA-2026
ANCOLI-OSA-2026
KUSHIDA-OSA-2026
GOTTLIEB-OSA-2026
MEHRA-OSA-2026
WHITE-OSA-2026
KAPUR-OSA-2026

house Pointers

href
/self/
label
STUDself. For everyday sleep duration and routines, see STUDself.

positive Guidance

status: DONE
reviewed At: 2026-09-18
professional Count: 15
scope: content-and-positive-titles-only

learn Article

article

format version

presentation

complete-card

overview

sections

id
understand-the-airway
role
explanation
title
What happens during sleep apnea?
intro
The useful starting point is the breathing pattern, rather than how loud someone snores or which device they own.
items
- label
  Understand the interruption behind an unrefreshing night
  text
  The upper airway is the passage through the nose, mouth and throat that carries air toward the lungs. In obstructive sleep apnea, or OSA, that passage repeatedly narrows or closes while the person is asleep. Breathing effort can continue even when little air moves. An apnea is a pause in airflow; a hypopnea is a qualifying reduction in airflow. Events can lower blood oxygen or briefly rouse the brain, interrupting sleep without a remembered awakening. NHLBI explains why time in bed and restorative sleep can diverge: the person may have had enough opportunity to sleep, while breathing repeatedly disrupted it. OSA is the most common type. Central sleep apnea involves a different problem with the signals that drive breathing, so an OSA treatment explanation does not cover every form of apnea.
  source ids
  nhlbi-overview
  aasm-diagnosis
- label
  Recognize why apnea belongs in everyday health discussions
  text
  Terry Young and colleagues' 1993 Wisconsin Sleep Cohort paper used overnight laboratory studies in 602 employed adults aged 30–60, rather than only people already referred to a sleep clinic. It found previously unrecognized sleep-disordered breathing in both women and men. Paul Peppard's 2013 analysis later used 1,520 cohort participants aged 30–70 and modeled prevalence with age, sex and body mass index. Its estimates rose when applied to later US weight distributions. These studies helped establish that the problem belongs in ordinary adult health conversations. They were population studies, not trials showing which treatment any one person needs. Their historical percentages also depend on the scoring rules and samples used; neither an old prevalence estimate nor a risk factor can tell you what happened in your own airway last night.
  source ids
  young-prevalence
  peppard-prevalence
- label
  Make room for symptoms beyond stereotypical snoring
  text
  A sleepy, heavier, older man who snores is one recognizable presentation, but it is not the definition of OSA. NHLBI describes women reporting fatigue, headaches or insomnia, and notes that risk increases during and after menopause. Sonia Ancoli-Israel's sleep-and-aging research also makes older-adult sleep symptoms a legitimate subject of assessment. Feeling tired is broader than sleepiness: fatigue can mean low energy, whereas sleepiness means difficulty remaining awake. Neither is specific to apnea. Someone living alone may have no witness to a pause, and someone who snores may have another explanation. The practical response is to describe the actual symptoms and history, including medicines and nighttime urination, rather than deciding whether you look like the usual patient.
  source ids
  nhlbi-symptoms
  nhlbi-women
  ancoli-profile
  nhlbi-diagnosis
id
recognize-your-situation
role
application
title
What belongs in the first conversation?
items
- label
  Bring the pauses someone has noticed
  text
  If someone describes snoring followed by silence, a gasp or a choking sound, report the sequence to a clinician. NHLBI lists stopped-and-restarted breathing and gasping as symptoms worth discussing. Snoring is vibration in a narrowed passage; a witnessed pause raises a different question about interrupted airflow. A partner's description or an existing recording can help explain that question, but neither establishes the event count or the cause. You do not need someone to monitor every night before making an appointment. Bring what is already known, along with daytime sleepiness, the usual sleep schedule and any relevant health conditions. A clinician can then decide whether a sleep study is appropriate. For an invented example, a household member notices a pause followed by gasping and the sleeper reports struggling to stay alert during the day. Their useful account keeps the two observations separate: what was witnessed at night and what the person experiences afterward. It does not turn a remembered pause into an hourly event count. They bring the existing information to a clinician rather than delaying until someone has recorded a whole night. If a later night sounds quieter, that single change does not establish whether the underlying question is resolved. The next step still depends on clinical assessment and any indicated testing. Sleepiness affecting driving requires immediate attention to safe transport. The example shows what an observation can contribute—and why it cannot supply the diagnosis, severity or treatment setting by itself.
  source ids
  nhlbi-symptoms
  nhlbi-diagnosis
  aasm-diagnosis
- label
  Explain how the next day feels after enough time in bed
  text
  If a full-looking night still leaves you unrefreshed, describe what that means: struggling to stay awake, needing unexpected naps, waking with a headache or having difficulty concentrating. NHLBI includes these kinds of sleep and daytime symptoms in its public education. The connection is plausible because OSA can interrupt sleep repeatedly, but a symptom is not proof of that mechanism. Short sleep, insomnia, body-clock timing, medicines and other health problems can also contribute. A sleep history helps distinguish lack of sleep opportunity from poor sleep despite enough opportunity. If you have nodded off while driving or at work, lead with that safety information rather than leaving it until the end of the visit.
  source ids
  nhlbi-symptoms
  nhlbi-overview
  nhlbi-diagnosis
  aasm-diagnosis
  aasm-safety
- label
  Ask what the proposed sleep test will measure
  text
  If you have been offered a home test, ask why it fits your history and what happens after a negative or unclear result. Vishesh Kapur's AASM task force recommends technically adequate home testing for selected uncomplicated adults whose symptoms suggest increased risk of moderate-to-severe OSA. Uncomplicated means that the history does not raise important competing breathing or sleep problems requiring broader monitoring. A laboratory study records more of the sleep itself as well as breathing. The distinction is useful when you have insomnia, heart or lung disease, opioid use or another relevant condition. A convenient location is one consideration; the more important question is whether the test can answer the clinical question.
  source ids
  aasm-diagnosis
  nhlbi-diagnosis
- label
  Describe the treatment difficulty that needs solving
  text
  If you already have a diagnosis, say both what improved and what prevents treatment use. Air leaking toward the eyes, dry mouth, nasal congestion, pressure discomfort or trouble falling asleep are useful specifics. Patil's AASM PAP guideline includes troubleshooting and objective monitoring as part of treatment, rather than treating a prescription as the endpoint. Ramar's oral-appliance guideline likewise includes dental oversight and follow-up sleep testing. A treatment can lower breathing events under ideal conditions yet provide little benefit if it cannot be used during sleep. Bringing the actual obstacle lets the care team consider fit, support or an alternative. It does not require you to choose a pressure, appliance or operation yourself.
  source ids
  aasm-pap
  aasm-oral
  nhlbi-living
id
read-the-sleep-study
role
findings
title
How do the test and its numbers fit together?
items
- label
  Let clinical testing turn a suspicion into a diagnosis
  text
  Polysomnography, often shortened to PSG, is the laboratory sleep study. It records signals that identify sleep and wakefulness alongside breathing, oxygen and other measurements. A home sleep apnea test, or HSAT, generally collects fewer signals. Kapur's 2017 AASM guideline places both inside a comprehensive evaluation and follow-up pathway. It recommends laboratory testing when significant cardiorespiratory disease, potential breathing-muscle weakness, suspected inadequate ventilation, chronic opioid use, previous stroke or severe insomnia makes a limited home study unsuitable. Hypoventilation means not moving enough air to meet the body's needs; it is a broader question than counting upper-airway obstructions. Questionnaires can help identify risk, but a questionnaire score alone cannot diagnose OSA. Test selection is therefore about what could be missed, as well as what might be found.
  source ids
  aasm-diagnosis
  nhlbi-overview
- label
  Read events per hour with the correct denominator
  text
  The apnea-hypopnea index, or AHI, counts qualifying breathing events per hour actually asleep. Many home tests instead report a respiratory event index, or REI, using monitoring time because they do not directly identify all sleep and wake periods. For example, 60 events divided by six hours asleep gives 10 per hour; dividing the same events by eight monitored hours gives 7.5. This arithmetic illustrates why awake time can dilute a home-test result; it is not a way to rescore your own study. AASM's public explanation also notes that many home tests miss events associated only with brief brain arousals. Adult severity categories commonly start at 5, 15 and 30 events per hour. A clinician reads those bands together with symptoms, oxygen changes and test quality, rather than treating the number as a complete account of burden.
  source ids
  aasm-safety
  aasm-diagnosis
  uspstf-screening
  aasm-adult-management
- label
  Compare scoring rules before comparing two reports
  text
  An oxygen desaturation is a fall in the blood-oxygen reading. An arousal is a brief shift toward wakefulness detected by brain-wave recording. The diagnostic guideline explains that one hypopnea rule accepts a 3% oxygen drop or an arousal, while another requires a 4% oxygen drop without counting arousal alone. The resulting AHI can differ even for the same person. Home equipment, sleep time, sensor quality and the amount of back-sleeping or dream sleep can add further differences. This explains why a report deserves interpretation rather than a simple pass/fail reading. Ask which event rule was used and whether the recorded night answered the original question. AASM recommends PSG after a negative, inconclusive or technically inadequate single HSAT; it also allows consideration of another PSG when an initial laboratory result is negative but clinical suspicion remains.
  source ids
  aasm-diagnosis
  aasm-arousal-scoring
id
understand-treatment-options
role
findings
title
What do the main treatments actually do?
items
- label
  Understand PAP as support for the airway during sleep
  text
  Positive airway pressure, or PAP, supplies pressurized air through a mask to help hold the airway open. CPAP supplies a continuous pressure; APAP adjusts pressure within the prescribed setup; bilevel PAP uses different pressures for breathing in and out. These are different delivery approaches, not rankings of who has the best machine. Susheel Patil and colleagues' 2019 guideline strongly recommends PAP for adults with OSA and excessive sleepiness, and conditionally recommends it for impaired sleep-related quality of life or hypertension. It supports CPAP or APAP for ongoing routine OSA care. The strength of each recommendation reflects the evidence and tradeoffs for that outcome. PAP supports breathing while used; a few comfortable nights do not establish that the underlying OSA has disappeared.
  source ids
  aasm-pap
  nhlbi-treatment
- label
  Connect treatment benefit to breathing control and regular use
  text
  Efficacy asks whether a treatment controls breathing when applied. Effectiveness also asks whether the person can use it in ordinary life. In a three-month, multicenter study of adults with severe OSA, Terri Weaver and colleagues found that longer nightly CPAP use was associated with a greater likelihood of returning to normal sleepiness and daily-function measures. Different outcomes had different use-response patterns. The study was not a randomized assignment to a universal safe number of hours. NHLBI advises using prescribed PAP during all sleep, including naps, and bringing the device when traveling. The useful lesson is to solve a mask or comfort problem early, so more of the actual sleep period receives treatment, rather than treating an administrative minimum as proof that every outcome is protected.
  source ids
  weaver-use
  nhlbi-living
- label
  Ask how a custom oral appliance will be fitted and checked
  text
  A mandibular advancement appliance holds the lower jaw farther forward to help keep the airway open. Ramar, Dort and their AASM/AADSM colleagues recommend considering oral appliances for adults with OSA who cannot tolerate CPAP or prefer an alternative. Their guideline favors a custom, adjustable device over a non-custom device. Adjustable means that a qualified dentist can change the position as part of the treatment process. This is not the same as buying an ordinary snoring guard. The dentist checks dental or jaw effects and changes in the bite; the sleep clinician checks whether breathing is controlled. Follow-up sleep testing matters because quieter snoring and a comfortable fit do not by themselves establish that OSA is adequately treated.
  source ids
  aasm-oral
  aasm-followup
- label
  Keep weight-related treatment in the full breathing plan
  text
  Weight management can help when excess body weight contributes to OSA, but the degree of improvement varies and another contributor can remain. In December 2024, the FDA approved tirzepatide, sold as Zepbound, for moderate-to-severe OSA in adults with obesity, together with a reduced-calorie diet and increased physical activity. The supporting studies included 469 adults without type 2 diabetes, followed for 52 weeks: one trial enrolled PAP users, the other people unable or unwilling to use PAP. Malhotra and colleagues reported larger reductions in AHI than with placebo. This is a studied prescription option for a defined population, not evidence that any weight-loss product cures apnea. Medication selection requires review of adverse effects and contraindications; FDA identifies gastrointestinal effects and serious risks, including restrictions for medullary thyroid cancer history or MEN2. Weight loss or less snoring alone is not permission to stop prescribed airway treatment.
  source ids
  fda-tirzepatide
  surmount-osa
  aasm-followup
- label
  Read trial improvements as averages with clear limits
  text
  In SURMOUNT-OSA, the average starting AHI was approximately 50 events per hour and average body mass index was approximately 39. At 52 weeks, the additional AHI reduction with tirzepatide compared with placebo averaged 20.0 events per hour in the non-PAP trial and 23.8 in the PAP trial. These are between-group differences, not a promised decrease for each person. A lower average AHI also does not mean every participant's apnea resolved. The trials measured breathing events, weight and other outcomes over a year; they did not establish that every long-term cardiovascular complication is prevented. Gastrointestinal adverse effects were most common, and the manufacturer funded the trials. The size of the breathing improvement is useful evidence, while the population, follow-up duration and sponsor remain part of interpreting it.
  source ids
  surmount-osa
  fda-tirzepatide
id
weigh-the-open-questions
role
perspectives
title
Where do reasonable clinical choices differ?
intro
Some questions involve genuinely incomplete outcome evidence. Others involve choosing between supported approaches for different people; that is not a disagreement over whether apnea exists.
items
- label
  Separate population screening from evaluating your symptoms
  text
  Screening means looking for a condition in people who are not presenting with a recognized concern. The 2022 USPSTF review found insufficient evidence to judge the overall benefit versus harm of routine adult OSA screening. Its I statement includes adults whose symptoms are unrecognized or not reported as a concern; it is neither a recommendation for nor against screening. It does not apply to someone presenting with symptoms or referred for suspected OSA. Professional groups also differ on targeted screening of higher-risk populations because risk, evidence thresholds and settings differ. This uncertainty is about a preventive strategy, not a reason to dismiss gasping or disabling sleepiness. Tell a clinician about the concern you actually have, rather than waiting for a universal screening policy.
  source ids
  uspstf-screening
  aasm-screening-advisory
- label
  Match the convenience of home care to the information needed
  text
  Home testing and home initiation of APAP can make care easier to access for suitable adults. A laboratory pathway can answer broader questions or provide supervised pressure adjustment. Patil's guideline supports either home APAP initiation or laboratory titration in adults without significant comorbidities, and either CPAP or APAP for ongoing treatment. Titration means adjusting pressure to control breathing events, not diagnosing severity from a pressure number. These supported alternatives do not make remote care automatically inferior or a shipped device automatically sufficient. Both approaches need education, monitoring and a route to solve problems. Discuss the medical history, available support and what will happen if symptoms, leak or machine data do not match the expected response.
  source ids
  aasm-pap
  aasm-diagnosis
  aasm-followup
- label
  Choose outcomes that matter alongside the AHI
  text
  OSA is associated with hypertension and cardiovascular disease, and the American Heart Association discusses it as relevant to heart care. Association alone does not prove that a particular treatment prevents heart attacks or strokes. In the SAVE randomized trial, 2,717 adults with moderate-to-severe OSA and existing coronary or cerebrovascular disease received usual care with or without CPAP. Most were minimally sleepy; average CPAP use was 3.3 hours nightly. Over an average 3.7 years, adding CPAP did not significantly reduce the main combined cardiovascular endpoint, while snoring, sleepiness and quality-of-life measures improved. This does not erase symptom benefits or settle the question for every population and pattern of use. It does explain why clinicians should discuss the expected outcome specifically, while continuing ordinary blood-pressure and cardiovascular care.
  source ids
  save-trial
  aha-cardiovascular
  aasm-pap
- label
  Discuss selected surgery as an evaluated option
  text
  Airway surgery changes anatomy; implanted hypoglossal nerve stimulation activates a nerve controlling tongue movement to help maintain airflow. Bariatric surgery addresses obesity rather than directly reshaping the throat. None is interchangeable with the others. David Kent's 2021 AASM guideline recommends discussing sleep-surgeon referral with PAP-intolerant or PAP-unaccepting adults with BMI below 40, and bariatric referral with eligible adults with obesity and BMI at least 35 who cannot accept or tolerate PAP. It generally suggests PAP first even with a major airway anatomic abnormality. These referral recommendations are not an instruction to have an operation. Selection, risks, possible residual OSA and patient preferences still need specialist assessment. The practical choice is an informed consultation when appropriate, not treating a social-media transformation as an operative plan.
  source ids
  aasm-surgery
  nhlbi-treatment
id
make-followup-useful
role
application
title
How can care keep working over time?
items
- label
  Bring symptoms and device data to the same follow-up
  text
  A machine download can report use, leak and estimated residual events: breathing events detected while treatment is running. These are useful observations, but the device does not measure every aspect of sleep or directly certify next-day alertness. AASM describes device estimates as manufacturer-dependent, and its follow-up guidance allows laboratory assessment of unexplained PAP data. Report how you actually feel alongside the download. Improvement in the report and persistent sleepiness can coexist, so a clinician may need to assess sleep opportunity, other conditions or whether treatment is working as expected. A low displayed number is information for that conversation, not a reason to dismiss continuing symptoms.
  source ids
  aasm-safety
  aasm-followup
  nhlbi-diagnosis
- label
  Treat comfort problems as solvable care problems
  text
  Leak, dryness, congestion, claustrophobia and difficulty sleeping with a mask can limit usable treatment time. NHLBI advises contacting the care team about these problems; mask choices, humidification or adjustments made by the team may help. The appropriate change depends on what is causing the problem, rather than the most popular suggestion online. Explain whether discomfort happens as you fall asleep, throughout the night or when you wake. Patil's recommendations support education and early troubleshooting, including selected remote monitoring. Needing support does not show that you failed treatment. It identifies the practical problem that has to be solved for the prescribed therapy to provide benefit.
  source ids
  nhlbi-living
  aasm-pap
- label
  Ask whether a change makes reassessment useful
  text
  Sean Caples and colleagues' 2021 AASM guidance distinguishes follow-up from automatically repeating a sleep study. Routine retesting is not recommended for an asymptomatic person doing well on PAP. Reassessment can be appropriate when symptoms persist or recur despite good use, when weight changes substantially, when cardiovascular disease changes or when unexplained device data raise a question. The guidance recommends testing the response to non-PAP treatments, which can include an oral appliance or surgery. This gives a concrete question for a follow-up visit: what has changed, and what would another test help decide? A clinician determines the timing and method; quieter snoring or a better morning alone does not answer it.
  source ids
  aasm-followup
- label
  Keep dental follow-up with an oral-appliance plan
  text
  An oral appliance is a continuing treatment, not just a fitting appointment. The lower-jaw position may be adjusted, and a dentist checks comfort, tooth and jaw effects, and changes in how the teeth meet. That meeting is the bite, or occlusion. The AASM/AADSM guideline calls for periodic dental and sleep-clinician visits and follow-up sleep testing. Report new dental discomfort or a changed bite rather than quietly accepting it as the price of quieter nights. The care team needs both parts of the picture: whether the appliance is tolerable and whether it controls the breathing disorder. A device being comfortable and a device being effective are separate questions.
  source ids
  aasm-oral
- label
  Keep everyday sleep habits beside apnea care
  text
  A regular opportunity to sleep and an agreed lifestyle plan can support care, but neither explains away measured airway obstruction. NHLBI describes physical activity, weight management and selected side-sleeping among possible parts of treatment. Side-sleeping is relevant when position influences airway blockage; it is not evidence that every case resolves in that position. Ask about alcohol, sedating medicines and other substances in the history rather than making unreviewed medication changes. Continue the agreed breathing-treatment plan while the clinician reviews its response. For everyday sleep duration and routines, see [STUDself](/self/). General sleep habits and treatment of a breathing disorder answer related, but different, questions.
  source ids
  nhlbi-treatment
  nhlbi-diagnosis
  aasm-followup
id
check-common-claims
role
cautions
title
What should a claim check conclude?
intro
These are evidence judgments about the claims below, not a diagnosis or clearance for an individual. The fuller explanations above show what each judgment depends on.
items
- label
  Bring snoring with breathing pauses to clinical care
  text
  Claim: Loud snoring with breathing pauses is a reason to seek clinical evaluation. Verdict: established. NHLBI identifies pauses, gasping and daytime sleepiness as symptoms to discuss. This supports evaluation; it does not establish OSA from sound alone or mean that every person who snores has apnea.
  source ids
  nhlbi-symptoms
- label
  Use a wearable alert to open the testing question
  text
  Claim: A wearable sleep score can diagnose obstructive sleep apnea. Verdict: not. A generic sleep score is not the clinician-selected diagnostic study in AASM guidance. Some consumer devices have specifically authorized notification features, which are different from a general score and still require clinical interpretation and evaluation. An alert can prompt care; a reassuring score cannot finish the diagnostic question.
  source ids
  aasm-diagnosis
  fda-watch-notification
  wearable-question
- label
  Understand why PAP is a major treatment option
  text
  Claim: PAP is first-line treatment for many adults with moderate or severe OSA. Verdict: established. PAP is a major airway-support treatment. Patil's guideline most directly states a strong recommendation for excessive sleepiness and conditional recommendations for sleep-related quality of life and hypertension. Severity is interpreted with that clinical picture, rather than used here as a self-prescription rule.
  source ids
  aasm-pap
  nhlbi-treatment
- label
  Confirm the breathing response after weight change
  text
  Claim: Losing weight always replaces the need to treat moderate-to-severe OSA. Verdict: not. Weight-related interventions can improve OSA in appropriate populations; improvement is not universal resolution. AASM follow-up guidance allows reassessment after substantial weight change. The result and clinical review, rather than the scale alone, inform whether an existing treatment should change.
  source ids
  surmount-osa
  aasm-followup
- label
  Read universal screening claims as unsettled evidence
  text
  Claim: Every adult should be screened for OSA even with no symptoms. Verdict: disputed. USPSTF found insufficient evidence to judge routine screening, while some professional advice supports screening selected high-risk groups. Insufficient evidence is not proof that screening cannot help. It does not prevent assessment when someone presents with symptoms or concern.
  source ids
  uspstf-screening
  aasm-screening-advisory
- label
  Ask about a custom oral appliance when it fits the care plan
  text
  Claim: Custom oral appliances can be an option when PAP cannot be used. Verdict: established. The AASM/AADSM guideline supports consideration for CPAP intolerance or a preference for alternate therapy, with qualified dental care and follow-up testing. That conclusion applies to a supervised treatment pathway, not every retail mouthguard.
  source ids
  aasm-oral
- label
  Review treatment changes with the prescribing clinician
  text
  Claim: A few good nights mean you can stop prescribed PAP on your own. Verdict: talk. Better nights may reflect effective treatment rather than disappearance of the disorder. PAP benefits depend on use, and changes after improvement, weight loss or another intervention belong in a clinical reassessment. This is not a rule to continue through every adverse effect without help: contact the treating team when treatment is causing problems.
  source ids
  weaver-use
  aasm-followup
  nhlbi-living
id
take-the-next-step
role
next_steps
title
What is one useful move now?
items
- label
  Describe nighttime breathing and daytime symptoms to a clinician
  text
  Arrange a clinical conversation about concerning breathing or daytime symptoms. Prepare four short lines: what someone has heard overnight, whether you gasp or wake choking, what staying awake feels like the next day, and whether driving or work has become unsafe. NHLBI describes the history, risk factors and medicines as part of evaluation. A diary can help organize information, but you do not need a perfect two-week record before care. These observations help the clinician decide what needs investigation. They do not provide a home diagnosis or establish a need for a device.
  source ids
  nhlbi-diagnosis
  nhlbi-symptoms
  aasm-safety
- label
  Try recording the pattern already available
  text
  Write down the usual sleep hours, snoring or observed pauses, gasping, morning headaches, naps and any unintended daytime sleep. Include existing observations from someone sharing the room and the medicines or substances that could affect sleep. A sleep diary can make this easier to describe, as NHLBI explains. It does not measure AHI or prove which condition is responsible. If sleepiness threatens safety, seek help promptly instead of waiting to complete a log.
  source ids
  nhlbi-diagnosis
  nhlbi-symptoms
  aasm-safety
- label
  Try asking about the whole testing and treatment pathway
  text
  At the visit, ask: Why this test, what happens if it is unclear, and how will treatment response be checked if OSA is found? If treatment is already difficult, bring the specific obstacle and ask what support or alternatives fit the result. Kapur, Patil and Ramar's guidelines describe different parts of that connected pathway. The purpose is to understand the next decision and the follow-up, rather than to leave with an unexplained number or a device you cannot use.
  source ids
  aasm-diagnosis
  aasm-pap
  aasm-oral
id
choose-safety-and-care
role
cautions
title
When should safety come first?
items
- label
  Arrange a safe alternative when you are too sleepy to drive
  text
  If you have nodded off at a light, fallen asleep driving or had a near miss, do not make the next trip a test of willpower. Avoid driving when sleepy, arrange another way to travel and tell a clinician promptly what happened. AASM's public safety guidance connects excessive sleepiness with impaired performance and recommends reporting ineffective treatment. Its commercial-driver certification rules are specific to that setting; this article does not issue a return-to-driving clearance. A better device number or a few better mornings cannot by itself establish safe alertness for the next journey.
  source ids
  aasm-safety
  nhlbi-overview
- label
  Get appropriate care for urgent symptoms
  text
  This is a reading companion, not a diagnosis, device prescription, or sleep-lab visit. Witnessed breathing pauses, gasping, crashing daytime sleepiness, or unrefreshing sleep after a full-looking night belong with a qualified clinician. Chest pain, fainting, one-sided weakness, or sudden breathlessness need emergency care. Do not start, stop, or change prescribed airway treatment from this text. This page does not treat one airway or promise an outcome.
  source ids
  nhlbi-symptoms
  medical-emergencies
- label
  Use the research as a reading companion
  text
  Named sources. Honest paraphrase of the finding. Not medical, legal, or financial advice.
  source ids
  aasm-diagnosis
  aasm-pap

related

sleep
attention
fitness

sources

id
nhlbi-overview
title
Sleep Apnea — What Is Sleep Apnea?
url
https://www.nhlbi.nih.gov/health/sleep-apnea
kind
official
accessed at
2026-10-01
supports
Explains OSA and central apnea, airway interruption, sleep quality and daytime function.
limitations
Public education; does not diagnose one person or specify therapy settings.
id
nhlbi-symptoms
title
Sleep Apnea — Symptoms
url
https://www.nhlbi.nih.gov/health/sleep-apnea/symptoms
kind
official
accessed at
2026-10-01
supports
Describes witnessed pauses, gasping, sleepiness, fatigue, headache, insomnia and nighttime urination as symptoms to discuss with a clinician.
limitations
Symptoms overlap other conditions; adult teaching here does not apply pediatric management.
id
nhlbi-diagnosis
title
Sleep Apnea — Diagnosis
url
https://www.nhlbi.nih.gov/health/sleep-apnea/diagnosis
kind
official
accessed at
2026-10-01
supports
Explains the role of medical history, risk factors, sleep studies, a diary and medicine review.
limitations
No self-diagnosis, mandatory diary duration or personal test order.
id
nhlbi-treatment
title
Sleep Apnea — Treatment
url
https://www.nhlbi.nih.gov/health/sleep-apnea/treatment
kind
official
accessed at
2026-10-01
supports
Explains PAP modes, oral devices, lifestyle measures and how selected operations work.
limitations
Broad patient education; clinical indications and device settings need individual assessment.
id
nhlbi-living
title
Sleep Apnea — Living With
url
https://www.nhlbi.nih.gov/health/sleep-apnea/living-with
kind
official
accessed at
2026-10-01
supports
Covers PAP during all sleep, including naps, along with travel, mask leak, comfort and clinical follow-up.
limitations
Does not establish a universal number of hours or routine repeat-study schedule.
id
nhlbi-women
title
Sleep Apnea — Sleep Apnea and Women
url
https://www.nhlbi.nih.gov/health/sleep-apnea/women
kind
official
accessed at
2026-10-01
supports
Explains menopause-related risk and symptoms that overlap with insomnia, fatigue and headache.
limitations
General population information, not diagnosis from age, sex or reproductive stage.
id
young-prevalence
title
The occurrence of sleep-disordered breathing among middle-aged adults
url
https://pubmed.ncbi.nlm.nih.gov/8464434/
kind
study
accessed at
2026-10-01
supports
Young et al. 1993 studied 602 randomly sampled employed adults aged 30–60 in a sleep laboratory and found substantial unrecognized breathing disturbance in women and men.
limitations
This summary draws on the PubMed abstract. The historical Wisconsin sample and scoring rules do not establish current national prevalence or treatment effectiveness.
id
peppard-prevalence
title
Increased prevalence of sleep-disordered breathing in adults
url
https://europepmc.org/article/MED/23589584
kind
study
accessed at
2026-10-01
supports
Peppard et al. 2013 modeled prevalence using 1,520 Wisconsin participants aged 30–70, with age, sex and BMI estimates applied to NHANES distributions.
limitations
This summary draws on the primary abstract; the full text was not inspected. Historical prevalence estimates do not give a person's present diagnostic probability or show an intervention's effect.
id
aasm-diagnosis
title
Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea
url
https://www.aasm.org/resources/clinicalguidelines/diagnostic-testing-osa.pdf
kind
guideline
accessed at
2026-10-01
supports
Kapur et al. 2017 covers clinical evaluation, laboratory versus home-test selection, relevant coexisting conditions, negative or inconclusive home-test follow-up and hypopnea definitions.
limitations
Adult clinician guideline. This article draws on its recommendations and discussion of methods; the evidence tables have not been independently reanalyzed.
id
aasm-safety
title
FAQs: Sleep Disorders, Fatigue, and Professional Operators
url
https://aasm.org/advocacy/public-safety-faq/
kind
professional
accessed at
2026-10-01
supports
Explains AHI versus REI, the monitoring-time denominator, unmeasured arousals, device estimates, leak and drowsy-driving precautions.
limitations
Occupational focus; certification thresholds and restrictions are not generalized to all adults.
id
aasm-adult-management
title
Clinical Guideline for the Evaluation, Management and Long-term Care of Obstructive Sleep Apnea in Adults
url
https://link.springer.com/article/10.5664/jcsm.27497
kind
guideline
accessed at
2026-10-01
supports
Explains assessment and management across several aspects of OSA. The common severity thresholds in this article are also supported by USPSTF definitions.
limitations
Historical guideline; newer topic-specific recommendations take precedence. The publisher abstract and recommendations were accessible, but a readable full severity table was not available.
id
aasm-arousal-scoring
title
Polysomnography for Obstructive Sleep Apnea Should Include Arousal-Based Scoring: An American Academy of Sleep Medicine Position Statement
url
https://link.springer.com/article/10.5664/jcsm.7234
kind
guideline
accessed at
2026-10-01
supports
Explains arousal-based versus oxygen-only hypopnea scoring, the 3%/arousal versus 4% rules and why home testing may miss arousal-related events.
limitations
This summary draws on the publisher abstract. A scoring position statement does not provide independent evidence of treatment benefit.
id
aasm-pap
title
Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline
url
https://link.springer.com/article/10.5664/jcsm.7640
kind
guideline
accessed at
2026-10-01
supports
Patil et al. 2019 gives a strong recommendation for sleepiness and conditional recommendations for quality of life and hypertension. It also covers CPAP/APAP, starting treatment at home or in a laboratory, education, troubleshooting and monitoring.
limitations
Publisher preview; subscription full text not inspected. Not a pressure-setting guide or universal cardiovascular-prevention claim.
id
weaver-use
title
Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning
url
https://europepmc.org/article/MED/17580592
kind
study
accessed at
2026-10-01
supports
Weaver et al. 2007 followed adults with severe OSA for three months in a multicenter, quasi-experimental study, examining how longer CPAP use related to different outcomes.
limitations
This summary draws on the primary abstract; the full text was not inspected. The observed use-response associations do not establish a universal safety threshold or the result of randomly assigning hours of use.
id
aasm-oral
title
Clinical Practice Guideline for the Treatment of Obstructive Sleep Apnea and Snoring with Oral Appliance Therapy: An Update for 2015
url
https://link.springer.com/article/10.5664/jcsm.4858
kind
guideline
accessed at
2026-10-01
supports
Ramar et al. describes custom adjustable appliances, CPAP intolerance or treatment preference, dental oversight, bite effects and follow-up testing.
limitations
Adult treatment guidance; publisher preview rather than full evidence review. Not every mouthguard or every patient's preferred treatment.
id
fda-tirzepatide
title
FDA Approves First Medication for Obstructive Sleep Apnea
url
https://www.fda.gov/news-events/press-announcements/fda-approves-first-medication-obstructive-sleep-apnea
kind
official
accessed at
2026-10-01
supports
The December 20, 2024 approval concerns OSA in adults with obesity alongside lifestyle measures. It describes 469 adults without type 2 diabetes in two 52-week trials, contraindications and adverse effects.
limitations
Historical approval announcement, not a claim about the number of approved medicines in October 2026. Current individual prescribing needs current label review.
id
surmount-osa
title
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity
url
https://pubmed.ncbi.nlm.nih.gov/38912654/?dopt=Abstract
kind
study
accessed at
2026-10-01
supports
Malhotra et al. 2024 reports randomized trials, starting AHI/BMI, between-group AHI differences at 52 weeks, gastrointestinal effects and Eli Lilly funding.
limitations
This summary draws on the primary abstract and its results. The trial population and one-year endpoints do not establish a universal cure, a dosing instruction or cardiovascular-event prevention. The publication links an erratum; any changes in inaccessible full text have not been reviewed.
id
aasm-followup
title
Use of polysomnography and home sleep apnea tests for the longitudinal management of obstructive sleep apnea in adults: an American Academy of Sleep Medicine clinical guidance statement
url
https://link.springer.com/article/10.5664/jcsm.9240
kind
guideline
accessed at
2026-10-01
supports
Caples et al. 2021 gives six follow-up statements: routine repeat studies are unnecessary for asymptomatic PAP users, while non-PAP treatment response, recurrent symptoms, weight or cardiovascular changes and unexplained device data can warrant testing.
limitations
Clinician guidance with expert opinion; does not mandate the same test/timing for every change.
id
aasm-surgery
title
Referral of adults with obstructive sleep apnea for surgical consultation: an American Academy of Sleep Medicine clinical practice guideline
url
https://link.springer.com/article/10.5664/jcsm.9592
kind
guideline
accessed at
2026-10-01
supports
Kent et al. 2021 describes surgical-referral discussions for PAP intolerance or nonacceptance, BMI criteria for sleep and bariatric referrals, and initial PAP treatment when major anatomic abnormalities are present.
limitations
A referral discussion is not a recommendation to undergo an operation. This article uses the final published guideline, not the 2020 draft.
id
aha-cardiovascular
title
Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association
url
https://europepmc.org/article/MED/34148375
kind
guideline
accessed at
2026-10-01
supports
Yeghiazarians et al. 2021 discusses OSA's relevance to cardiovascular evaluation and care.
limitations
This summary draws on the complete primary abstract, not the full text. Associations discussed in a scientific statement do not establish guaranteed prevention by PAP.
id
save-trial
title
CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea
url
https://europepmc.org/article/MED/27571048
kind
study
accessed at
2026-10-01
supports
McEvoy et al. 2016 studied 2,717 adults with OSA and established cardiovascular disease. Average CPAP use was 3.3 hours nightly over 3.7 years; the main combined event outcome did not improve significantly, while symptoms and quality of life did.
limitations
This summary draws on the complete primary abstract, not the full text. Participants were mostly minimally sleepy men with existing disease; the intention-to-treat result under observed use does not settle every population or pattern of use.
id
aasm-screening-advisory
title
Obstructive Sleep Apnea Screening Health Advisory
url
https://aasm.org/advocacy/position-statements/sleep-apnea-screening-health-advisory/
kind
professional
accessed at
2026-10-01
supports
Advises annual screening in selected high-risk groups, including people with heart failure, elevated or resistant blood pressure, atrial fibrillation, type 2 diabetes or stroke.
limitations
Health advisory, distinct evidence threshold from a population-screening systematic review.
id
uspstf-screening
title
Obstructive Sleep Apnea in Adults: Screening
url
https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/obstructive-sleep-apnea-in-adults-screening
kind
guideline
accessed at
2026-10-01
supports
Explains the 2022 I statement, the inclusion of unrecognized symptoms, the exclusion of people presenting with concerns, and differences from targeted-screening recommendations.
limitations
Adult primary-care screening; not symptomatic diagnostic evaluation, pregnancy, children or occupational fitness rules.
id
fda-watch-notification
title
Sleep Apnea Notification Feature (SANF) — FDA 510(k) Summary K240929
url
https://www.accessdata.fda.gov/cdrh_docs/pdf24/K240929.pdf
kind
official
accessed at
2026-10-01
supports
Defines notifications for possible moderate-to-severe apnea in previously undiagnosed adults. The feature does not diagnose or manage apnea, and absence of a notification does not establish absence of apnea.
limitations
Device-specific regulatory record, not authorization of all watches or a substitute for clinical diagnosis.
id
wearable-question
title
Apple Watch has warned me about possible sleep apnea for 3 months straight. Has anyone else experienced this?
url
https://www.reddit.com/r/SleepApnea/comments/1uymxc3/apple_watch_has_warned_me_about_possible_sleep/
kind
question_signal
accessed at
2026-10-01
supports
A public question about repeated possible-apnea notifications illustrates why readers need to distinguish a general sleep score, a notification and diagnostic testing.
limitations
Unverified anonymous experience; comments and agreement do not establish device performance, diagnosis, prevalence or treatment benefit.
id
medical-emergencies
title
Recognizing medical emergencies
url
https://medlineplus.gov/ency/article/001927.htm
kind
official
accessed at
2026-10-01
supports
Explains when chest symptoms, breathing difficulty, loss of consciousness and sudden weakness need emergency care.
limitations
General emergency information; not a claim that these signs are caused by OSA.
id
ancoli-profile
title
Sonia Ancoli-Israel — UCSD Profiles
url
https://profiles.ucsd.edu/sonia.ancoli-israel
kind
professional
accessed at
2026-10-01
supports
Documents sleep and behavioral-sleep certifications, education awards, and research on sleep-disordered breathing in older adults.
limitations
Professional contribution context, not evidence diagnosing fatigue in an older adult.

professional panel

name
Paul E. Peppard
credential
PhD in Epidemiology; Professor, Population Health Sciences, UW–Madison
official url
https://cde.wisc.edu/staff/peppard-paul/
public usefulness
Official biography explains obesity, sleep-disorder predictors and population consequences; his prevalence paper helps explain why apnea is an ordinary adult-health question.
contribution
2013 modeled prevalence update and the distinction between population estimates and one person's sleep test.
boundary
Historical prevalence modeling cannot diagnose an individual or establish weight loss as a guaranteed cure.
reviewed at
2026-10-01
name
Susan Redline
credential
MD, MPH; Harvard-affiliated sleep researcher, verified in NHLBI workshop participant record
official url
https://www.nhlbi.nih.gov/events/2021/toward-precision-medicine-circadian-rhythm-blood-pressure-and-chronotherapy
public usefulness
Named speaker in public NHLBI sleep/blood-pressure education and coauthor of the SURMOUNT-OSA publication opened here.
contribution
Population and trial perspectives on sleep-related cardiovascular questions, measurement and applicability.
boundary
The workshop documents her role and public teaching, not an individual risk forecast. The separate Harvard role page was not accessible.
reviewed at
2026-10-01
name
Atul Malhotra
credential
Professor of Medicine, UC San Diego; lead investigator/author of the SURMOUNT-OSA paper
official url
https://profiles.ucsd.edu/atul.malhotra
public usefulness
Official profile exposes airway-mechanics research and public publications explaining why different OSA treatments fit different mechanisms.
contribution
Tirzepatide trial findings and distinction between treating a defined population and promising a cure to everyone.
boundary
Professor role verified directly; trial abstract used for medical findings. Industry-funded trial participation does not make every treatment claim independent.
reviewed at
2026-10-01
name
Naresh M. Punjabi
credential
MD, PhD; sleep physician and epidemiologist, qualifications documented in FDA-hosted curriculum vitae
official url
https://www.fda.gov/media/175861/download?attachment=
public usefulness
CV documents invited education on apnea physiology, diagnosis, cardiometabolic effects and Sleep Heart Health Study findings.
contribution
Connects daytime function and cardiometabolic outcomes to the study population and research method.
boundary
The 2023 CV documents a historical professional role, not his latest administrative title or a personal prognosis.
reviewed at
2026-10-01
name
Nancy Collop
credential
MD; former AASM president and Emory sleep specialist as documented by AASM
official url
https://aasm.org/american-academy-of-sleep-medicine-names-emory-sleep-specialist-nancy-collop-md-president/
public usefulness
Professional-society public announcement records her sleep education and standards role; diagnostic guidance supplies the factual rules rather than her title.
contribution
Clinical selection and oversight of home testing, rather than treating a portable monitor as a retail diagnosis.
boundary
The 2011 announcement documents a historical role, not a current presidency. The former Emory link no longer supplied an individual biography.
reviewed at
2026-10-01
name
Susheel P. Patil
credential
MD, PhD; University Hospitals sleep physician; lead author of 2019 AASM PAP guideline
official url
https://www.uhhospitals.org/for-clinicians/articles-and-news/authors/susheel-patil-md
public usefulness
Official clinician-education articles discuss OSA care and research; public guideline states treatment recommendations and follow-up requirements.
contribution
Distinguishes recommendations for sleepiness, quality of life and hypertension, and includes education and troubleshooting in treatment.
boundary
A guideline is not a brand recommendation, pressure prescription or guarantee of cardiovascular prevention.
reviewed at
2026-10-01
name
Terri E. Weaver
credential
PhD, RN; Dean and Professor Emerita, University of Illinois Chicago College of Nursing
official url
https://nursing.uic.edu/profiles/terri-weaver/
public usefulness
Official biography explains her Functional Outcomes of Sleep Questionnaire and international treatment-outcome education.
contribution
Connects nightly treatment use to daytime sleepiness and functioning, including the practical ability to use treatment.
boundary
The use-response study is quasi-experimental and does not establish a universally sufficient number of hours.
reviewed at
2026-10-01
name
Allan I. Pack
credential
MBChB, PhD; University of Pennsylvania sleep researcher, verified in publisher author information
official url
https://link.springer.com/article/10.5664/jcsm.1450
public usefulness
Named author of the public professional editorial Sleep Medicine: Strategies for Change; contributor to PAP-use research cited in the opened guideline.
contribution
Explains care delivery and treatment use in everyday life, including what happens after a device is supplied.
boundary
The author information documents a historical affiliation; the Penn faculty page was not accessible. Editorial authorship does not establish treatment effectiveness.
reviewed at
2026-10-01
name
Sonia Ancoli-Israel
credential
PhD; Professor Emeritus of Psychiatry and Professor of Research, UC San Diego; certified in sleep and behavioral sleep medicine
official url
https://profiles.ucsd.edu/sonia.ancoli-israel
public usefulness
Official profile documents education recognition and longstanding sleep, aging and apnea research, including an aged-population prevalence program.
contribution
Addresses sleep symptoms in older adults and the need to consider explanations beyond inevitable aging.
boundary
Professional contribution establishes relevance, not that every older adult's fatigue is apnea.
reviewed at
2026-10-01
name
Clete A. Kushida
credential
MD, PhD; Stanford Professor and Chief of the Division of Sleep Medicine
official url
https://profiles.stanford.edu/clete-kushida
public usefulness
Official biography records sleep-teaching programs, textbooks, PAP trials and standards leadership.
contribution
Explains objective treatment evaluation and the range of sleep and airway questions involved in OSA care.
boundary
Trial and teaching leadership are not a personal titration or surgery plan; final 2021 surgery guideline supplies referral criteria.
reviewed at
2026-10-01
name
Daniel J. Gottlieb
credential
MD, MPH; coauthor of 2021 AASM surgical-referral guideline, with VA Boston/Brigham affiliation documented at publication
official url
https://link.springer.com/article/10.5664/jcsm.9592
public usefulness
Public guideline translates treatment-selection evidence into referral discussions; official publisher verifies qualifications.
contribution
Places alternative treatments within a comprehensive care decision without promising cardiovascular protection.
boundary
The guideline documents his role at publication. The Harvard page was not accessible, so a current biography has not been verified.
reviewed at
2026-10-01
name
Reena Mehra
credential
MD, MS; tenured Professor, Division of Pulmonary, Critical Care and Sleep Medicine, University of Washington
official url
https://pulmccsm.uw.edu/people/faculty/reena-mehra
public usefulness
UW faculty/research pages document multicenter sleep research and mentoring; UW publicly lists a 2026 Sleep Apnea and Arrhythmias teaching session.
contribution
Connects cardiovascular and sleep concerns with the clinical interpretation of diagnosed OSA.
boundary
The listed affiliation is with the University of Washington. A faculty role or teaching session does not demonstrate that PAP prevents every arrhythmia.
reviewed at
2026-10-01
name
Vishesh K. Kapur
credential
MD, MPH; UW Medicine Sleep Center founder and lead author of 2017 AASM diagnostic-testing guideline
official url
https://pulmccsm.uw.edu/research/sleep
public usefulness
Official research page explains epidemiology, guideline development and home-versus-laboratory care research; UW lists public sleep-disordered-breathing teaching.
contribution
Explains clinical test selection, the meaning of a negative home test and the importance of scoring definitions.
boundary
Guideline applies to clinicians' adult evaluation, not a consumer wearable score or personal test order.
reviewed at
2026-10-01
name
Kannan Ramar
credential
MBBS, MD; lead author, AASM/AADSM oral-appliance guideline; Mayo Clinic affiliation documented at publication
official url
https://link.springer.com/article/10.5664/jcsm.4858
public usefulness
Public society guideline offers a clear route from treatment preference/intolerance to custom fitting and verified response.
contribution
Distinguishes supervised oral-appliance care from generic snoring guards, including dental and sleep follow-up.
boundary
Publication-era credential/role verified; guideline does not say every individual will respond to an appliance.
reviewed at
2026-10-01
name
Leslie C. Dort
credential
DDS; dental coauthor, AASM/AADSM oral-appliance guideline; University of Calgary affiliation documented at publication
official url
https://link.springer.com/article/10.5664/jcsm.4858
public usefulness
Public guideline brings qualified dental oversight, bite changes and titratable devices into the ordinary treatment conversation.
contribution
Explains dental effects and long-term fit alongside the breathing effects of mandibular advancement.
boundary
Coauthorship verifies a specific contribution; it is not an endorsement of a retail appliance or a personal dental consultation.
reviewed at
2026-10-01
name
David Kent
credential
MD; lead author, 2021 AASM surgical-referral guideline; Vanderbilt affiliation documented at publication
official url
https://link.springer.com/article/10.5664/jcsm.9592
public usefulness
Final public guideline explains who should discuss surgical consultation and why a referral is different from selecting an operation.
contribution
Explains when PAP intolerance or nonacceptance supports a discussion of surgical referral and which selection criteria apply.
boundary
Guideline recommendation is to discuss referral; risks, anatomy, residual disease and a person's preferences remain individual questions.
reviewed at
2026-10-01

Download original public profile Download complete article

End of Sleep apnea